rfhg_47057.1

Basic information about the TSS

---

TSS ID: rfhg_47057.1 Species: human Chr: chr3		Start: 71582232 End: 71582262 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3444909,EH38E2213559)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000648895.1:120 GeneID: 27086 HGNC/MGI_ID: HGNC:3823 UniProt_ID: A0A3B3ISQ7 Nearer transcript ids and distances: ENST00000649610.1:284

Gene_name: forkhead box P1 Gene_symbol: FOXP1 Gene_synonyms: 12CC4 HSPC215 QRF1 hFKH1B Gene_source: HGNC:3823

TATA-Box annotation

---

Distance to TSS:	1481
Nearest PromoterID:	NR_146142
Entrez ID:	27086
Nearest Unigene:	Hs.59368
Nearest Refseq:	NM_032682
Nearest Ensembl:	ENSG00000114861
Gene Name:	forkhead box P1
Gene Alias:	12CC4|HSPC215|MFH|QRF1|hFKH1B
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.387097
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@FOXP1 p2@FOXP1 p3@FOXP1 p4@FOXP1 p5@FOXP1 p6@FOXP1 p7@FOXP1 p8@FOXP1 p9@FOXP1 p10@FOXP1
Sample		p1@FOXP1	p2@FOXP1	p3@FOXP1	p4@FOXP1	p5@FOXP1	p6@FOXP1	p7@FOXP1	p8@FOXP1	p9@FOXP1	p10@FOXP1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	10.52	1.36	2.34	2.34	0.78	1.36	1.17	0.78	1.56	1.75
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	11.53	1.01	2.63	3.03	0.20	0.81	0.61	1.42	1.42	2.23
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	8.87	0.96	2.12	3.47	0.39	0.96	0.58	2.12	1.16	2.12
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	13.31	1.04	1.87	3.12	0.83	0.83	0.21	0.21	1.25	1.87
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	11.70	0.90	2.02	3.15	0.67	0.90	1.12	0.67	1.35	1.80
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	14.92	1.36	1.36	2.52	1.55	1.16	0.19	0.58	2.13	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	11.33	1.74	1.31	4.79	1.09	1.96	1.53	0.65	1.96	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	7.99	1.45	1.45	3.15	0.97	1.70	0.48	0.48	1.45	2.66
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	10.90	1.71	1.71	2.78	1.28	0.43	1.07	0.43	1.07	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	14.49	2.90	0.00	8.69	2.32	0.58	1.74	0.58	2.32	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	9.70	2.43	2.02	4.45	0.81	1.62	0.40	0.40	1.21	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	13.01	4.07	1.63	3.25	2.85	0.81	2.03	1.22	0.81	3.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	3.87	0.32	5.80	6.29	0.16	1.29	0.64	1.29	0.81	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	4.51	0.00	3.16	4.21	0.45	0.30	0.00	1.50	0.60	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	3.29	0.22	3.29	3.29	0.22	0.22	0.22	0.88	1.54	2.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	6.29	0.25	4.53	4.78	0.25	0.75	0.50	1.01	0.50	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	3.71	0.44	3.71	3.28	0.22	0.87	0.22	1.53	0.87	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	3.80	0.42	4.22	2.95	0.00	3.37	0.42	1.27	0.00	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	4.80	0.00	5.33	3.73	0.00	1.07	1.07	0.00	2.13	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	4.66	0.30	4.21	3.46	1.05	1.35	0.15	0.90	1.05	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	4.81	0.13	3.21	4.81	0.00	1.60	0.40	1.20	1.20	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	4.32	0.35	5.18	2.59	0.35	1.04	0.86	1.21	0.69	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	4.91	0.39	5.30	4.27	0.78	1.29	0.26	1.55	1.03	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	5.58	0.00	5.10	2.91	0.00	1.70	0.49	1.46	0.73	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	3.35	0.00	4.64	3.10	0.00	1.55	0.00	0.52	1.29	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	3.80	0.00	5.38	3.48	0.95	2.53	0.00	0.95	1.58	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	5.49	0.55	6.59	2.20	0.55	1.10	0.00	1.10	0.00	2.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	9.43	0.24	7.54	5.42	0.47	0.94	0.00	0.71	0.94	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	5.65	0.32	4.20	3.72	0.32	0.97	0.32	0.48	1.94	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	4.71	0.18	7.96	3.98	0.54	0.72	0.54	1.45	0.90	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	5.86	0.84	7.96	2.93	0.42	1.47	0.00	1.05	1.05	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	7.82	0.00	9.57	3.52	0.00	0.98	0.20	0.78	1.56	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	7.39	0.21	9.29	3.17	0.00	1.69	0.42	1.69	0.63	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	5.77	0.82	9.40	4.12	0.82	1.32	0.82	1.48	1.81	2.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	8.60	0.00	8.41	4.67	0.56	1.12	0.56	0.75	0.56	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	9.96	1.34	9.39	4.02	0.19	1.15	0.19	0.77	1.34	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	10.83	2.04	7.97	3.88	0.61	1.43	0.41	1.43	0.82	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	8.46	0.60	7.66	3.63	0.20	1.61	0.40	0.40	0.60	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	9.72	1.89	6.75	4.32	0.54	2.43	0.27	0.27	0.27	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	12.72	0.48	12.48	1.44	0.48	1.44	0.96	0.48	1.20	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	9.65	0.47	9.88	2.59	0.47	0.94	0.00	0.47	1.41	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	9.66	0.73	9.37	2.34	0.44	1.76	0.59	1.02	2.20	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	14.76	0.63	13.29	2.74	0.84	2.53	0.21	1.05	1.05	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	14.16	0.17	12.24	4.20	1.22	3.67	0.35	0.70	0.87	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	18.47	1.00	13.05	3.01	1.00	1.41	0.80	0.40	0.80	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	15.82	1.16	15.35	3.49	2.09	1.63	0.70	0.93	1.16	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	15.35	0.24	12.95	2.64	0.72	1.92	0.48	0.48	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	15.80	2.98	13.41	1.49	1.19	2.98	0.60	0.60	0.30	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	22.26	1.20	26.33	3.35	1.20	2.63	0.24	1.20	1.44	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	20.83	1.21	26.89	3.24	1.21	1.82	0.20	1.42	1.62	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	34.64	0.61	30.95	2.46	1.84	3.28	0.41	2.05	2.66	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	38.47	0.89	27.57	2.22	0.44	4.89	0.00	1.78	3.56	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	41.98	0.00	0.00	27.98	0.00	279.84	293.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	39.03	1.77	21.65	1.06	0.71	5.68	0.00	3.90	2.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	37.45	0.66	20.55	1.33	0.99	3.65	0.00	1.99	2.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	9.23	2.52	17.62	0.00	1.68	4.19	0.84	15.10	15.10	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	13.32	0.92	16.99	2.76	0.46	5.97	0.00	4.59	3.21	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	34.68	0.00	27.23	1.30	0.32	5.51	0.65	6.81	2.92	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	33.72	0.32	22.16	2.25	0.32	9.96	0.00	3.53	3.53	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	24.83	1.57	21.37	0.63	1.57	4.09	1.26	8.17	4.40	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	39.48	0.71	28.20	2.12	1.41	3.53	0.00	5.64	2.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	26.92	0.56	16.82	2.24	0.00	3.93	0.00	2.80	2.80	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	15.13	1.59	19.11	3.98	0.00	9.55	0.00	14.33	10.35	5.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	17.67	0.00	25.48	0.34	1.02	2.72	0.00	4.08	2.04	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	27.62	0.32	32.17	2.60	1.62	8.45	0.32	2.60	2.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	32.30	0.00	22.36	1.42	1.77	4.97	0.00	4.26	1.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	80.82	0.00	452.59	549.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	7.90	0.00	0.00	0.00	31.59	0.00	252.72	221.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	23.89	0.00	5.36	0.49	0.49	1.95	0.00	2.44	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	28.26	0.50	8.43	0.50	0.50	2.48	0.00	0.50	0.50	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	22.99	0.00	7.97	0.94	0.94	0.47	0.00	1.41	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	8.94	0.00	5.30	2.32	0.33	0.00	0.33	0.99	1.99	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	16.40	0.62	4.33	1.86	0.62	2.78	0.00	1.86	1.24	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	14.06	0.00	6.42	2.45	0.00	3.36	0.31	4.28	0.61	0.61
Adipocyte - breast, donor1	11376-118A8	7.13	4.91	1.11	0.63	0.32	3.64	1.90	1.11	1.27	0.00
Adipocyte - breast, donor2	11327-117E4	10.27	4.49	0.80	1.12	0.00	4.33	2.89	0.48	0.48	0.32
Adipocyte - omental, donor1	11473-119C6	8.65	8.65	2.54	1.15	0.13	2.42	4.07	0.76	1.27	0.00
Adipocyte - omental, donor2	11474-119C7	5.98	1.49	2.24	0.00	0.00	0.00	0.00	2.24	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	5.69	2.01	2.01	1.67	0.00	2.01	0.33	2.01	1.34	0.33
Adipocyte - perirenal, donor1	11476-119C9	5.74	1.91	3.83	1.28	0.00	1.91	0.00	1.91	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	2.20	0.00	0.00	0.00	0.00	2.20	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	15.36	4.06	0.00	0.00	0.00	0.90	2.26	1.81	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	4.34	0.17	0.00	0.52	0.00	0.35	0.52	0.52	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	49.48	20.34	1.96	1.17	0.39	2.15	6.65	5.87	2.74	0.98
Adipocyte differentiation, day04, donor2	13022-139D7	41.44	16.73	8.75	1.80	0.00	0.77	4.89	1.29	2.06	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	40.14	19.79	1.67	1.39	0.28	4.18	7.81	0.56	2.51	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	36.44	15.87	0.59	1.76	0.00	3.53	8.82	0.59	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	19.79	4.83	0.40	1.69	0.00	0.88	2.57	1.61	1.45	0.88
Adipocyte differentiation, day08, donor2	13023-139D8	40.99	18.72	1.29	1.61	0.00	4.52	10.01	3.23	2.90	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	19.19	4.80	0.00	0.53	0.53	4.80	4.27	1.07	1.60	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	16.14	2.78	0.00	0.00	0.00	1.67	3.90	1.67	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	4.57	0.42	0.00	0.42	0.00	1.25	0.83	0.42	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	23.86	6.03	1.00	1.00	0.00	1.51	3.01	1.00	2.51	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	16.04	6.54	0.98	0.65	0.00	3.27	2.62	0.00	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	8.22	2.44	0.00	0.30	0.00	0.30	1.83	0.30	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	13.48	2.65	1.99	0.88	0.44	0.88	0.66	0.88	0.00	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	5.74	0.72	0.00	0.00	1.08	0.36	0.36	0.00	0.00	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	4.79	1.20	0.00	1.20	0.00	0.00	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	7.38	0.00	10.79	0.54	0.36	0.72	0.00	1.26	0.72	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	0.00	3.35	0.00	0.00	3.35	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	3.49	0.21	8.83	0.41	0.00	1.23	0.00	1.03	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	45.43	31.01	1.49	0.57	1.03	8.47	11.56	4.92	5.61	0.23
Anulus Pulposus Cell, donor2	11463-119B5	25.47	9.55	1.22	0.49	0.73	6.12	6.12	7.59	2.69	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	18.87	9.88	3.59	0.45	0.45	8.99	2.70	1.80	3.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	16.06	3.04	1.30	0.00	0.43	8.25	2.17	1.74	3.04	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	4.28	2.14	0.00	0.00	10.70	6.42	0.00	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	21.52	5.38	7.47	0.60	0.60	7.77	2.09	1.20	4.18	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	15.18	5.06	5.06	0.00	1.26	0.00	1.26	1.26	6.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	17.82	5.28	3.30	0.66	0.66	3.96	0.66	0.00	1.98	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	19.49	6.82	2.60	0.65	0.00	8.12	1.62	2.27	4.55	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	16.50	6.80	3.40	0.97	0.00	9.71	1.46	1.94	2.91	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	19.00	6.53	2.38	1.19	0.59	4.75	2.38	2.38	3.56	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	20.72	7.53	4.52	0.38	1.51	8.29	1.51	3.39	7.16	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	29.75	4.35	5.08	0.00	1.45	10.16	0.00	5.08	3.63	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	11.28	5.02	8.78	0.00	0.00	5.02	1.25	1.25	5.02	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	21.58	7.25	4.28	0.49	1.32	2.14	1.15	1.32	2.14	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	25.93	4.09	1.36	0.00	2.73	6.82	1.36	1.36	5.46	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	18.25	5.28	2.87	0.15	0.30	2.56	1.66	3.17	5.43	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	26.25	4.29	3.21	0.54	0.54	8.57	2.14	3.75	4.29	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	26.64	3.40	4.91	0.19	0.76	8.69	1.51	2.83	4.72	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	28.60	5.61	4.54	0.53	2.14	7.22	0.53	2.14	1.34	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	23.41	4.88	0.98	0.00	0.00	15.61	1.95	2.93	5.85	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	23.05	4.31	3.65	0.00	0.17	6.14	1.33	3.15	6.80	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	28.82	4.80	6.00	0.00	2.40	14.41	0.00	3.60	8.41	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	7.08	0.00	0.00	0.00	0.00	0.00	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	24.87	5.66	4.12	0.51	0.69	10.29	1.37	3.77	5.66	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	0.00	0.00	4.19	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	17.48	1.94	6.80	0.00	0.49	10.19	1.94	1.94	3.40	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	16.70	4.93	7.21	0.38	0.76	5.31	1.14	1.90	4.17	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	15.75	2.42	7.27	0.00	1.21	2.42	0.00	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	17.67	3.99	3.42	0.57	0.00	7.98	1.14	3.99	2.85	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	19.03	4.70	3.21	0.00	0.86	4.70	0.64	3.21	2.99	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	17.55	3.36	4.39	0.00	0.26	4.90	1.03	2.32	2.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	17.36	0.47	2.35	0.00	1.41	6.57	1.41	1.41	4.22	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	19.29	2.89	6.75	0.00	0.32	9.97	0.96	2.57	3.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	12.84	5.71	2.14	0.00	0.00	4.99	1.43	1.43	2.14	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	19.30	3.51	1.17	0.00	1.17	11.11	1.75	0.58	2.92	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	17.46	4.82	3.91	0.60	0.60	8.73	3.01	2.11	4.22	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	24.95	4.75	4.75	0.00	1.19	8.32	1.19	3.56	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	14.75	6.10	1.53	0.00	1.02	7.63	2.03	2.03	2.03	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	21.90	4.84	3.57	0.76	1.02	8.66	1.27	4.08	2.80	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	17.79	1.27	3.81	0.64	0.64	2.54	1.27	0.64	1.91	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	17.69	6.47	2.16	0.00	0.43	8.20	0.86	4.32	3.45	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	20.75	4.66	5.29	0.21	0.64	7.62	1.48	2.54	4.02	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	17.40	4.35	4.93	0.00	0.29	5.22	0.87	3.77	2.61	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	15.12	5.67	2.83	0.00	0.94	6.61	0.00	0.00	5.67	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	18.31	3.73	3.90	0.34	0.68	4.92	1.53	3.22	4.24	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	9.27	2.32	0.00	0.00	4.63	0.00	2.32	6.95	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	21.13	6.34	2.11	0.00	0.00	10.56	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	24.01	5.15	4.72	0.43	0.86	9.01	1.29	3.65	2.57	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	26.47	6.62	3.61	0.00	0.00	12.03	0.60	1.20	1.80	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	21.14	2.19	3.64	0.00	0.00	8.75	1.46	1.46	4.37	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	27.36	5.98	4.14	0.69	0.92	6.21	1.15	3.45	3.91	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	43.36	0.00	10.20	0.00	0.00	7.65	0.00	0.00	7.65	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	21.61	4.32	2.54	0.25	0.51	3.56	0.76	3.31	5.59	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	29.52	5.99	6.19	0.62	0.21	7.43	1.86	3.92	4.34	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	28.46	4.90	3.37	0.00	0.61	6.73	2.75	2.75	3.67	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	21.99	8.13	1.91	0.96	0.96	13.86	1.43	4.30	2.39	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	25.94	5.54	3.55	0.44	0.67	6.21	1.55	4.66	5.32	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	21.36	1.53	7.63	0.00	0.00	6.10	3.05	4.58	4.58	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	29.91	6.65	4.43	0.00	0.55	11.63	1.11	3.32	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	30.72	6.09	2.91	0.26	0.79	7.68	0.53	3.71	4.77	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	29.80	5.45	2.91	0.00	1.09	9.45	1.45	4.72	3.63	0.00
Astrocyte - cerebellum, donor1	11500-119F6	7.00	4.30	5.16	1.60	0.61	0.61	1.72	0.86	0.61	0.25
Astrocyte - cerebellum, donor2	11580-120F5	10.78	2.40	3.94	1.54	0.34	1.03	0.68	1.54	0.86	0.51
Astrocyte - cerebellum, donor3	11661-122F5	10.49	3.15	4.82	2.73	0.84	1.68	0.42	0.84	1.26	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	3.49	4.18	2.09	1.74	0.70	0.35	0.70	0.35	0.35	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	3.56	2.91	0.97	1.29	0.32	0.65	0.97	0.65	0.49	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	13.13	4.77	6.26	2.98	0.60	0.89	1.04	1.34	0.60	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	0.00	0.00	0.00	0.11	0.00	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor1	12241-129G9	10.72	25.37	2.35	3.92	2.09	0.78	2.88	0.78	1.05	3.40
Basophils, donor2	12242-129H1	28.14	59.89	5.05	2.53	2.89	1.80	13.71	3.25	0.72	2.16
Basophils, donor3	12243-129H2	24.25	14.99	8.08	4.26	5.59	3.67	2.94	5.73	1.91	3.09
Bronchial Epithelial Cell, donor1	11511-119G8	2.37	0.00	0.22	0.43	0.00	0.22	0.00	0.22	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	5.03	0.46	0.91	1.83	0.00	0.46	0.00	0.00	0.00	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	8.79	0.00	0.63	0.00	0.00	0.00	0.00	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	7.28	0.21	0.42	0.62	0.00	0.42	0.21	0.42	0.21	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	5.30	0.23	0.46	2.07	0.23	0.92	0.46	1.38	0.00	2.30
Bronchial Epithelial Cell, donor7	11769-123I5	2.52	0.54	0.18	0.90	0.00	0.72	0.54	0.54	0.36	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.31	22.36	3.92	2.37	0.10	5.77	3.40	2.78	3.30	0.93
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	30.28	6.06	1.40	0.00	7.92	5.59	5.36	3.03	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	6.08	13.75	8.95	4.16	1.92	2.24	3.84	1.60	1.60	2.24
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	31.03	0.00	0.00	10.34	0.00	0.00	0.00	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	25.92	15.78	11.27	9.58	4.51	3.94	1.13	5.07	2.82	3.94
CD14+ Monocytes, donor2	11305-117B9	40.09	12.81	13.18	7.05	5.01	8.91	3.16	3.16	2.97	1.67
CD14+ Monocytes, donor3	11381-118B4	40.18	14.93	9.88	6.37	5.49	6.37	1.98	5.05	3.29	5.05
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	6.23	70.19	2.26	6.23	0.28	4.25	13.30	1.70	3.96	2.26
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	7.58	67.10	0.38	5.31	4.55	3.03	6.44	4.17	3.03	2.65
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	6.25	87.12	1.64	11.18	0.99	2.63	10.19	4.27	2.63	2.63
CD14+ monocytes - mock treated, donor1	11863-125A9	25.30	1.45	3.76	2.31	0.14	3.90	0.14	2.60	1.59	2.46
CD14+ monocytes - mock treated, donor2	11873-125C1	17.20	2.41	4.22	2.41	0.30	2.41	0.30	0.30	0.30	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	30.80	1.18	5.21	4.03	0.00	2.84	0.00	1.90	0.24	2.61
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	17.74	1.51	2.51	1.17	0.17	2.51	0.17	1.00	0.84	0.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	6.90	1.66	1.93	1.10	0.28	2.76	0.28	0.55	0.55	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	11.65	2.23	3.47	2.23	0.50	1.24	0.25	1.49	0.74	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5.87	0.98	2.55	3.13	0.20	3.33	0.39	0.20	1.57	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	7.83	1.60	4.27	4.63	0.18	5.34	0.36	0.36	1.07	1.78
CD14+ monocytes - treated with BCG, donor3	11880-125C8	6.09	1.31	3.70	3.26	0.00	0.65	0.00	0.65	0.87	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	12.64	1.87	4.21	1.17	0.70	2.58	0.23	1.64	0.94	2.11
CD14+ monocytes - treated with Candida, donor2	11878-125C6	12.14	4.75	8.98	3.17	1.58	3.17	1.06	1.58	1.58	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	9.98	2.22	2.22	3.33	1.11	3.33	0.00	1.11	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	11.30	1.19	2.97	1.34	0.15	4.46	0.30	1.34	1.04	0.89
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	4.59	1.80	2.59	1.40	1.00	0.80	0.40	0.60	0.60	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	6.45	1.67	2.50	1.46	0.00	0.62	0.42	0.62	0.00	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	10.75	1.37	3.66	2.75	0.23	2.52	0.00	0.23	1.37	1.60
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	6.79	3.62	3.17	1.81	0.68	0.45	0.23	0.00	0.23	2.26
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	15.28	1.31	4.80	1.31	0.00	1.31	0.00	0.44	0.87	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	13.99	2.96	2.42	3.23	0.00	2.15	0.81	1.08	1.08	1.61
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	15.18	2.09	5.23	5.23	0.52	4.19	0.52	2.27	1.57	1.92
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	19.78	6.31	8.00	5.05	0.00	2.52	0.84	2.95	0.42	3.37
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	36.74	2.39	1.10	1.65	0.00	3.67	0.73	4.04	2.20	1.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	27.83	3.17	2.11	1.41	0.35	0.70	1.41	0.70	1.76	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	38.17	6.14	2.19	1.32	0.44	3.51	0.44	0.44	1.32	3.07
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	5.58	0.70	4.36	4.71	0.17	4.36	0.00	1.39	1.39	1.57
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	6.69	0.74	5.58	2.23	0.37	1.12	0.37	1.12	0.74	1.86
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	5.17	3.23	4.74	4.96	0.22	0.43	0.00	0.86	0.65	3.23
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	40.54	12.69	2.46	5.73	0.82	7.78	0.41	1.23	1.23	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	17.85	5.56	2.78	1.62	1.16	0.70	0.46	1.62	0.23	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	27.84	3.25	1.86	0.70	0.23	1.86	0.70	1.16	0.46	1.86
CD14+CD16+ Monocytes, donor1	11789-124B7	5.45	0.65	7.41	5.45	0.00	1.53	0.00	0.87	0.87	1.96
CD14+CD16+ Monocytes, donor2	11801-124D1	13.17	0.23	7.39	3.93	0.23	1.39	0.00	1.15	0.46	3.46
CD14+CD16+ Monocytes, donor3	11912-125G4	6.28	0.65	6.93	3.68	0.00	0.43	0.00	0.43	0.65	3.90
CD14+CD16- Monocytes, donor1	11788-124B6	1.71	0.31	16.51	7.16	0.00	2.18	0.31	1.40	1.40	2.49
CD14+CD16- Monocytes, donor2	11799-124C8	2.62	0.00	15.02	3.14	0.00	2.62	0.00	1.57	1.75	2.62
CD14+CD16- Monocytes, donor3	11910-125G2	4.46	0.22	22.07	8.03	0.00	1.11	0.00	1.11	0.89	3.79
CD14-CD16+ Monocytes, donor1	11790-124B8	11.99	0.51	11.99	7.91	0.00	1.28	0.00	1.28	1.02	5.10
CD14-CD16+ Monocytes, donor2	11800-124C9	14.49	0.66	11.64	4.83	0.00	2.20	0.44	2.63	0.88	3.95
CD14-CD16+ Monocytes, donor3	11911-125G3	13.26	0.42	9.90	8.63	0.00	2.32	0.00	0.84	1.26	5.90
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	46.74	77.23	4.06	0.00	97.55	10.16	0.00	2.03	8.13	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	49.49	86.78	4.07	1.36	130.85	6.78	4.07	4.07	5.42	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	49.71	73.53	5.18	3.11	98.38	3.11	7.25	6.21	4.14	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	42.64	62.90	8.00	0.53	95.95	7.46	5.33	4.26	10.66	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	47.17	76.66	3.75	1.61	121.15	3.22	4.82	6.97	8.04	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	61.07	89.85	3.51	0.70	122.84	4.21	9.13	7.02	4.91	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	51.77	61.96	2.35	0.00	121.57	7.06	6.27	7.06	4.71	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	44.82	68.55	1.32	0.00	105.46	7.91	10.55	5.27	9.23	0.00
CD19+ B Cells, donor1	11544-120B5	388.76	98.63	7.40	1.64	162.74	58.35	11.51	14.79	23.84	2.47
CD19+ B Cells, donor2	11624-122B4	369.24	79.07	4.35	0.73	117.52	46.43	17.41	19.59	30.47	0.00
CD19+ B Cells, donor3	11705-123B4	360.45	113.59	3.03	1.01	133.78	39.88	19.69	16.15	28.27	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	2.42	13.74	5.66	9.70	2.83	2.02	6.46	3.64	1.21	7.27
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	2.80	9.99	6.79	11.98	0.80	2.00	3.99	3.99	2.40	4.79
CD34+ Progenitors, donor1	11545-120B6	12.05	24.10	8.03	5.02	14.06	0.00	9.04	0.00	1.00	2.01
CD34+ Progenitors, donor2	11625-122B5	38.76	18.54	5.62	1.69	21.35	1.69	7.87	2.25	0.56	2.81
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	4.88	9.39	9.39	5.26	6.39	4.88	3.38	5.26	2.63	4.51
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	5.41	16.91	9.24	4.51	5.86	1.35	1.58	0.45	1.58	3.38
CD4+ T Cells, donor1	11225-116C1	287.07	161.75	0.00	2.14	74.62	40.70	24.28	23.21	16.78	0.36
CD4+ T Cells, donor2	11306-117C1	213.10	90.02	0.61	1.22	71.03	66.14	24.49	20.82	22.66	0.00
CD4+ T Cells, donor3	11382-118B5	241.86	94.55	0.30	0.30	57.34	33.55	19.82	25.92	17.99	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	23.99	58.70	0.51	0.26	53.85	3.83	4.08	1.02	1.53	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	34.81	65.13	1.12	1.35	66.71	8.09	3.59	4.04	6.06	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	23.00	57.20	0.00	0.57	72.44	7.19	4.02	2.87	6.32	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	91.03	82.02	1.90	0.47	356.52	9.48	6.64	4.27	7.59	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	92.00	80.06	0.00	1.40	349.05	11.94	10.53	4.92	13.34	2.81
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	85.70	59.33	0.00	0.00	253.81	26.37	3.30	13.18	9.89	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	14.02	55.93	0.14	0.72	10.26	3.76	6.94	1.45	2.75	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	42.37	40.67	0.51	0.68	14.57	21.35	5.08	6.61	6.44	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	35.63	33.05	0.00	1.45	18.70	22.57	5.32	3.87	6.13	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	69.93	60.07	0.00	0.45	106.70	16.14	7.17	3.59	7.62	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	58.35	53.81	0.35	1.05	106.21	8.73	9.08	1.75	6.64	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	84.92	89.76	0.44	2.20	145.63	8.36	7.92	6.16	3.52	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	29.51	89.81	1.26	1.26	56.92	5.90	7.17	1.26	1.69	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	25.97	57.55	0.42	1.66	33.87	27.01	5.40	7.27	8.52	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	17.71	47.11	0.33	0.67	22.72	35.42	4.68	3.01	5.35	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	79.95	149.84	0.54	1.09	214.01	21.48	10.61	10.33	10.06	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	76.64	139.35	1.07	2.14	249.75	16.08	6.43	9.11	12.33	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	98.63	87.87	1.79	0.00	175.74	30.48	12.55	8.97	12.55	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	17.62	83.81	0.00	0.74	5.01	3.34	9.46	2.23	2.04	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	13.43	65.85	0.00	0.00	1.95	3.47	5.42	3.25	3.03	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	10.30	69.35	0.00	0.63	0.84	1.89	5.88	2.94	2.52	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	64.21	98.59	0.51	2.02	30.34	3.03	13.15	1.01	3.54	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	69.32	115.68	0.43	1.30	37.26	3.47	12.56	3.03	3.90	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	76.27	178.68	0.00	1.74	27.02	4.36	18.74	9.15	2.61	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	37.12	108.38	0.99	0.00	51.47	4.45	10.39	8.41	6.93	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	25.85	88.63	0.00	1.85	45.24	5.54	7.39	2.77	7.39	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	15.35	87.94	0.00	0.00	40.48	2.79	9.77	5.58	2.79	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	39.60	92.77	2.49	0.83	75.88	4.98	9.69	4.43	1.94	2.49
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	37.05	111.65	1.72	0.74	79.75	7.36	9.08	4.91	1.96	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	24.64	169.40	1.54	0.00	66.22	10.78	6.16	6.16	4.62	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	27.22	116.39	1.43	0.00	49.78	5.37	11.10	5.37	2.86	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	29.08	117.72	0.00	4.15	37.39	5.54	9.69	2.77	5.54	0.00
CD8+ T Cells, donor1	11226-116C2	74.97	110.33	0.00	0.98	34.38	18.33	16.04	9.82	9.49	0.33
CD8+ T Cells, donor2	11307-117C2	57.44	42.42	0.00	1.50	6.38	23.28	15.02	5.63	5.26	1.13
CD8+ T Cells, donor3	11383-118B6	110.09	80.54	0.25	0.76	62.36	17.93	19.44	32.32	18.94	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	12.39	2.29	0.69	1.61	0.00	1.15	0.23	0.69	1.15	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	14.38	2.40	0.24	0.72	0.00	1.68	0.00	0.24	0.48	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	12.31	1.09	0.55	1.92	0.00	1.09	0.55	0.27	1.09	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	11.11	1.50	0.90	2.40	0.00	1.80	0.90	1.80	0.90	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	17.04	0.48	0.48	0.72	0.00	1.44	0.72	0.24	1.20	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	15.69	2.05	0.45	1.36	0.00	1.59	0.23	0.91	1.82	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	19.12	2.39	0.87	0.87	0.00	2.61	0.22	1.30	0.87	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	22.11	2.90	1.05	2.37	0.00	1.84	1.05	0.53	1.58	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	22.28	2.35	0.94	1.41	0.00	1.41	0.47	0.47	0.70	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	19.32	3.02	2.11	1.51	0.00	2.72	0.60	0.60	0.91	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	19.17	3.20	0.58	2.91	0.00	1.74	1.16	0.58	2.91	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	19.18	2.40	0.27	2.13	0.00	1.07	0.27	0.80	1.60	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	34.14	6.13	0.44	3.50	0.00	3.94	0.44	1.75	0.88	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	28.24	6.83	0.46	4.10	0.00	2.73	1.82	1.82	0.91	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	49.97	9.70	0.00	4.48	0.00	7.46	1.49	0.75	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	14.05	1.80	0.36	1.08	0.00	1.08	0.00	0.72	0.72	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	12.95	1.15	0.29	2.30	0.00	2.01	0.00	0.00	0.00	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	16.97	0.94	0.94	1.89	0.00	1.89	0.47	1.18	0.94	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	20.28	3.80	0.32	0.32	0.00	1.27	0.32	1.90	0.95	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	21.22	3.38	0.00	1.23	0.00	3.08	0.62	2.46	0.62	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	21.16	2.89	0.96	2.24	0.00	2.24	0.32	1.60	0.32	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	27.92	2.29	1.53	3.82	0.00	3.06	0.76	2.29	0.76	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	25.22	3.55	0.00	2.76	0.00	2.76	0.39	2.76	1.18	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	21.94	1.51	2.27	0.00	0.00	2.27	0.00	1.51	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	27.30	4.01	1.61	6.42	0.00	4.01	0.80	3.21	1.61	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	23.08	4.20	2.10	8.39	0.00	4.20	0.70	3.50	3.50	2.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	37.06	2.00	2.00	3.01	0.00	5.01	1.00	1.00	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	49.35	32.90	0.00	1.83	1.83	7.31	14.62	5.48	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	16.30	5.93	3.46	0.49	0.49	6.42	1.98	3.46	4.45	0.49
Cardiac Myocyte, donor3	11686-122I3	12.84	4.31	0.21	0.95	0.42	1.37	1.16	1.37	0.84	0.11
Chondrocyte - de diff, donor1	11261-116G1	14.56	6.59	3.47	1.04	0.69	15.25	2.08	11.44	1.73	1.04
Chondrocyte - de diff, donor2	11338-117F6	12.44	8.88	2.13	0.71	1.78	1.42	1.78	2.13	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	17.18	5.46	4.55	1.37	0.46	3.07	2.50	3.98	3.07	0.91
Chondrocyte - re diff, donor2	11339-117F7	66.25	14.32	46.55	0.90	0.00	1.79	2.69	1.79	0.90	1.79
Chondrocyte - re diff, donor3	11411-118E7	30.33	4.45	14.96	2.02	0.40	5.26	1.62	4.04	2.83	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	34.43	12.39	33.85	1.95	5.85	8.03	2.87	2.07	4.48	1.38
Ciliary Epithelial Cells, donor2	11323-117D9	27.15	4.49	53.01	0.64	4.49	7.27	1.92	3.42	4.49	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	28.67	3.54	61.51	1.59	5.22	4.51	0.53	6.19	3.54	0.80
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	29.07	18.43	4.49	7.43	2.84	1.65	6.60	2.29	1.93	3.85
Corneal Epithelial Cells, donor1	11526-119I5	5.49	0.66	0.44	0.66	0.00	0.00	0.00	0.66	0.00	0.44
Corneal Epithelial Cells, donor2	11606-120I4	6.83	0.00	1.14	1.14	0.00	2.28	1.14	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	9.20	0.00	0.00	1.53	0.00	1.02	0.00	0.77	0.26	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	8.42	2.64	1.16	2.64	1.16	1.98	0.33	0.50	0.83	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	6.31	2.52	0.95	2.52	1.26	1.26	0.32	0.32	0.00	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	6.90	0.00	6.90	3.45	0.00	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	6.05	0.76	0.76	1.40	0.65	0.65	0.22	1.08	0.43	1.19
Dendritic Cells - plasmacytoid, donor1	11228-116C4	48.85	8.54	5.81	3.76	8.54	3.42	2.05	3.42	4.78	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	26.77	3.92	3.92	1.96	7.18	0.00	1.96	0.65	1.96	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	28.55	1.45	4.84	5.81	7.26	0.97	1.94	0.97	0.48	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	23.01	6.50	0.00	1.33	0.33	1.83	2.00	2.50	0.67	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	12.32	2.93	0.00	1.17	0.00	0.00	0.59	0.59	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	17.82	4.24	0.28	0.28	0.00	1.70	2.26	1.98	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	29.88	3.54	0.79	0.79	0.79	0.39	0.79	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	20.07	4.65	0.58	0.29	0.87	0.58	0.29	0.87	0.58	0.29
Endothelial Cells - Artery, donor2	11341-117F9	22.82	3.29	0.24	1.18	0.24	7.29	0.94	2.82	0.71	0.00
Endothelial Cells - Artery, donor3	11413-118E9	19.28	4.03	0.35	1.40	0.53	0.88	1.40	1.75	1.40	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	19.51	5.10	0.44	3.55	1.33	1.77	2.66	2.22	1.77	1.11
Endothelial Cells - Lymphatic, donor2	11317-117D3	17.95	9.74	0.61	2.74	1.22	1.22	3.96	2.13	0.91	3.65
Endothelial Cells - Lymphatic, donor3	11393-118C7	20.30	11.84	1.13	3.38	2.26	1.13	1.69	0.56	0.28	1.69
Endothelial Cells - Microvascular, donor1	11265-116G5	13.37	3.27	0.00	0.89	0.00	4.16	0.89	4.46	0.89	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	14.58	2.60	0.00	0.52	0.00	1.04	0.00	1.04	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	19.71	1.70	0.28	0.99	0.57	1.42	0.28	2.69	0.99	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	30.41	7.20	0.80	0.80	1.60	4.40	2.80	6.40	1.60	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	11.01	4.19	0.00	0.00	0.52	3.14	0.52	2.10	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	50.44	17.02	2.73	6.59	4.60	5.96	7.33	3.60	4.72	4.22
Endothelial Cells - Umbilical vein, donor2	11324-117E1	51.06	9.56	3.04	5.87	0.87	4.13	3.04	1.96	0.65	2.61
Endothelial Cells - Umbilical vein, donor3	11400-118D5	63.14	11.36	3.79	6.84	3.18	2.56	3.91	1.71	1.10	2.56
Endothelial Cells - Vein, donor1	11267-116G7	31.85	3.41	0.00	0.00	1.14	1.14	0.00	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	10.48	1.40	0.00	1.40	2.10	0.00	1.40	0.70	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	21.98	2.98	0.47	1.41	0.63	2.36	0.47	1.41	0.16	0.47
Eosinophils, donor1	12244-129H3	60.99	76.23	0.00	0.00	30.49	0.00	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	24.75	8.25	1.65	13.20	3.30	3.30	3.30	1.65	0.00	6.60
Eosinophils, donor3	12246-129H5	17.83	7.13	0.00	10.70	3.57	0.00	0.00	0.00	0.00	10.70
Esophageal Epithelial Cells, donor1	11507-119G4	4.89	0.49	0.24	0.24	0.00	0.98	0.00	0.98	0.00	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	0.00	2.08	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	74.30	7.39	14.78	0.82	1.64	16.83	1.64	16.01	8.62	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	15.77	2.08	0.11	0.00	0.11	0.55	0.33	1.20	0.88	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	34.56	3.36	3.03	0.54	0.43	2.38	1.30	1.52	2.38	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	29.11	6.79	5.46	0.36	1.21	3.76	2.55	3.88	3.15	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	33.98	12.01	4.23	0.68	1.77	1.36	2.87	1.77	1.50	1.36
Fibroblast - Aortic Adventitial, donor2	11326-117E3	29.43	3.16	5.27	0.53	0.32	4.22	0.84	4.01	3.06	0.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	25.56	8.70	23.45	2.11	2.63	0.79	2.63	2.11	1.58	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	40.53	6.98	7.64	0.33	1.00	4.65	2.99	5.98	2.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	17.24	1.81	2.27	0.45	0.00	0.91	0.91	1.36	1.36	0.00
Fibroblast - Cardiac, donor2	11345-117G4	6.82	3.03	9.10	0.00	0.76	0.76	1.52	0.76	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	12.78	6.94	8.04	0.00	0.95	2.05	0.95	1.58	2.68	0.32
Fibroblast - Cardiac, donor4	11452-119A3	33.04	21.52	0.30	0.30	0.30	0.30	6.67	1.21	1.21	0.30
Fibroblast - Cardiac, donor5	11456-119A7	20.56	9.26	0.89	1.78	1.14	2.41	2.66	4.44	1.52	0.38
Fibroblast - Cardiac, donor6	11460-119B2	16.52	9.85	0.30	0.91	0.15	2.58	2.88	1.36	1.06	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	24.12	13.13	6.83	1.61	2.81	2.95	2.28	1.07	0.13	0.80
Fibroblast - Choroid Plexus, donor2	11572-120E6	53.50	18.98	10.35	1.29	4.31	5.18	3.88	1.73	5.18	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	41.01	5.86	11.72	0.00	4.39	5.86	0.00	2.93	5.86	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	59.50	5.07	0.23	0.69	0.23	2.08	0.69	2.31	0.69	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	30.02	6.78	1.02	0.68	0.00	2.37	2.54	0.34	1.87	0.00
Fibroblast - Dermal, donor1	11269-116G9	31.70	1.64	0.00	0.23	0.00	2.58	0.47	2.58	3.29	0.00
Fibroblast - Dermal, donor2	11346-117G5	11.32	2.83	0.00	0.00	0.00	0.00	1.42	1.42	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	23.94	2.42	0.00	0.00	0.00	2.66	0.97	3.02	1.69	0.00
Fibroblast - Dermal, donor4	11450-119A1	18.43	1.81	0.00	0.11	0.00	1.47	1.36	1.24	1.02	0.00
Fibroblast - Dermal, donor5	11454-119A5	26.34	0.87	0.00	0.70	0.00	1.74	1.05	2.27	1.05	0.00
Fibroblast - Dermal, donor6	11458-119A9	25.50	2.11	0.00	0.16	0.00	3.41	1.62	2.76	0.97	0.16
Fibroblast - Gingival, donor1	11237-116D4	28.74	10.83	0.00	0.00	0.00	3.96	5.62	1.25	1.25	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	24.89	6.81	1.05	1.05	0.00	1.05	4.98	0.52	0.79	0.52
Fibroblast - Gingival, donor2	11318-117D4	48.50	15.42	1.71	0.53	0.00	9.88	5.40	3.82	6.72	0.26
Fibroblast - Gingival, donor3	11394-118C8	32.10	9.57	0.00	0.10	0.00	1.55	7.35	2.32	1.45	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	35.32	25.97	1.04	0.00	0.00	10.39	8.31	5.19	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	44.40	12.51	4.05	0.53	0.00	9.34	4.23	1.59	3.17	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	47.55	11.22	1.25	0.31	0.00	1.40	6.39	2.03	1.71	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	45.57	17.31	1.62	0.41	0.00	3.38	7.03	1.08	2.43	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	37.76	7.41	8.82	1.76	0.00	0.00	4.94	0.00	1.06	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	47.97	13.45	4.09	0.58	0.00	3.07	5.26	3.07	1.75	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	44.59	13.50	4.23	0.82	0.00	3.82	6.27	1.64	2.59	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	62.74	18.32	9.76	1.54	0.00	3.95	4.61	1.86	2.63	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	37.27	11.59	9.54	3.37	0.00	4.40	6.16	2.05	1.47	1.47
Fibroblast - Lung, donor1	11270-116H1	8.16	10.87	0.00	0.00	0.00	0.00	2.72	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	58.19	17.91	0.00	0.00	0.00	4.48	4.48	1.49	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	49.59	8.02	0.63	0.00	0.00	4.64	3.17	3.17	4.64	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	17.49	10.83	0.00	0.00	0.00	0.83	4.17	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	1.40	0.00	0.00	0.00	0.00	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	6.16	1.12	0.56	0.00	0.00	0.00	0.28	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	29.64	4.87	1.62	0.81	0.41	0.00	2.44	0.41	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	3.99	0.00	0.00	0.00	0.00	3.99	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	11.91	5.96	0.00	0.00	0.00	0.00	5.96	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	38.02	9.31	0.19	0.58	0.00	6.21	3.69	1.55	2.91	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	64.46	10.92	0.30	0.46	0.00	2.12	6.37	2.58	2.58	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	58.44	11.32	0.00	0.31	0.00	0.92	7.65	1.22	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	33.58	17.55	4.96	1.14	0.38	4.96	5.72	2.29	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	34.29	8.64	5.67	1.08	0.00	7.02	4.05	1.89	1.89	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	50.22	15.31	4.99	2.67	0.00	4.18	6.38	4.18	2.09	0.81
Fibroblast - Pulmonary Artery, donor1	11250-116E8	7.74	3.21	0.33	0.33	0.22	1.44	2.32	2.10	1.77	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	6.91	3.45	0.20	0.00	0.00	0.00	1.42	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	14.03	1.34	0.00	0.00	0.00	1.34	0.67	1.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	14.23	1.98	0.00	0.00	0.00	1.19	0.79	0.79	1.58	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	13.89	6.15	16.07	2.58	0.20	1.79	2.58	0.99	0.60	1.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	7.99	1.95	1.60	1.95	0.00	0.53	1.42	0.18	0.18	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	21.88	4.14	0.99	0.99	0.00	0.99	1.58	1.58	0.99	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	17.45	10.53	11.43	1.20	0.00	1.20	5.11	0.60	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	17.16	9.61	2.91	1.84	0.00	1.94	3.02	3.02	0.43	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	9.87	2.78	11.89	1.77	0.00	0.51	2.02	1.01	0.51	1.52
Fibroblast - skin normal, donor1	11553-120C5	9.35	2.13	3.12	0.66	0.00	0.49	0.49	0.66	0.49	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	27.07	8.42	19.05	1.40	0.20	2.61	4.21	2.61	2.01	1.00
Fibroblast - skin normal, donor2	11561-120D4	17.18	4.62	8.64	0.90	0.00	2.51	1.41	2.61	0.50	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	19.34	8.46	19.04	2.12	0.30	0.91	4.84	1.51	1.21	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	15.49	3.98	2.32	1.49	0.00	2.40	2.49	1.16	1.41	0.91
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	49.40	11.80	4.44	2.91	0.17	7.01	3.59	3.76	1.37	1.03
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	10.84	2.30	8.21	0.99	0.33	0.00	1.31	2.63	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	10.01	1.17	4.15	0.64	0.00	1.60	1.07	1.92	0.32	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	20.75	5.06	2.02	0.67	0.00	2.19	0.67	1.69	0.51	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	2.82	2.51	0.63	1.10	0.00	0.31	1.73	1.10	1.25	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	0.00	0.00	0.00	0.00	0.00	22.16	88.64	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	107.20	6.10	10.46	9.59	0.00	5.23	0.87	6.97	0.87	6.10
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	14.91	0.87	0.00	0.35	0.17	4.33	0.17	0.87	1.04	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	20.30	1.30	1.56	0.78	0.26	2.60	0.52	3.12	1.30	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	16.35	0.77	0.51	1.53	0.00	2.30	0.77	1.28	0.51	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	3.06	0.77	1.53	1.53	20.67	1.53	0.00	2.30	2.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	1.28	0.00	1.91	2.55	17.87	1.28	0.00	0.64	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	3.14	0.29	0.86	7.70	27.10	3.42	0.00	2.28	2.85	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	1.65	0.28	1.65	16.55	0.55	1.93	0.00	0.83	0.83	5.52
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	5.48	0.46	5.25	14.16	5.48	0.91	0.46	1.83	1.83	6.39
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	3.76	0.59	0.79	6.93	19.81	1.19	0.00	0.99	0.79	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	1.85	0.00	1.59	11.63	3.17	1.85	0.26	0.53	1.59	2.91
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	9.46	0.98	6.85	19.24	5.54	0.98	0.33	1.96	0.65	6.52
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	2.21	0.44	1.33	9.29	30.96	1.77	0.00	0.44	1.33	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	3.11	0.85	0.71	2.97	14.56	2.54	0.14	1.84	0.99	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	3.94	0.62	1.48	3.69	7.88	0.86	0.37	0.74	0.49	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	1.61	0.00	0.27	2.95	18.80	0.81	0.00	0.81	1.34	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	5.08	0.62	0.74	1.12	1.12	0.50	0.37	0.87	0.74	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	4.98	0.83	0.42	1.94	2.35	0.69	0.14	0.69	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	4.47	1.02	0.41	1.42	6.51	1.42	0.61	0.41	1.02	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	6.16	1.60	0.91	0.91	0.91	2.28	0.23	0.46	1.60	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	7.85	1.49	0.75	1.99	1.49	0.87	0.25	0.50	0.50	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	6.12	1.53	0.22	1.75	3.28	0.87	0.66	0.22	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	6.50	2.36	0.89	2.95	3.25	2.07	1.18	0.59	2.07	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	6.04	2.38	0.79	2.23	4.13	1.11	0.64	0.48	0.79	1.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	2.90	0.45	1.12	1.79	4.24	1.12	0.22	0.22	0.67	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	6.86	2.82	0.60	2.22	2.82	3.02	0.81	0.81	1.41	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	9.67	1.87	2.37	2.04	2.54	1.87	1.19	0.85	0.68	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	7.80	5.59	1.42	3.10	5.50	0.98	2.04	0.44	0.89	0.98
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	10.82	9.68	1.98	2.39	2.29	2.50	3.12	1.25	1.66	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	9.56	8.20	1.37	1.54	2.05	1.37	2.90	0.34	0.68	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	9.63	3.21	1.33	2.21	1.00	1.11	1.22	0.89	0.66	1.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	5.32	7.15	1.66	1.75	5.24	1.25	1.75	0.67	0.50	0.92
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	4.29	7.35	0.20	1.84	3.47	0.61	1.43	1.02	0.41	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	9.28	6.19	0.62	1.44	0.83	1.65	1.44	0.00	2.68	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	8.65	3.92	1.27	1.73	0.46	1.04	1.61	1.27	1.04	0.81
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	6.84	5.17	0.83	2.67	1.00	1.00	4.00	1.00	1.17	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	7.49	3.53	1.32	0.88	0.44	1.54	1.32	1.76	1.54	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	8.86	5.78	1.72	2.09	0.37	1.23	0.98	0.98	0.98	0.86
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	8.92	5.02	2.11	1.30	2.27	1.78	2.76	1.46	1.30	1.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	5.45	5.77	1.28	3.21	1.28	2.89	3.53	1.92	1.60	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	7.58	2.65	0.47	0.95	0.66	1.33	1.61	0.66	0.66	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	5.22	6.96	0.32	1.27	0.16	1.27	2.85	0.47	0.63	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	8.51	4.26	0.30	0.00	0.61	1.82	2.74	0.30	1.22	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	6.69	3.35	1.46	1.78	0.63	0.94	1.57	0.73	1.25	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	4.17	8.78	0.44	0.44	0.66	0.88	3.95	0.66	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	6.45	3.65	0.84	0.84	0.84	1.96	2.52	1.40	2.24	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	7.04	2.59	1.11	0.74	0.46	0.74	1.48	0.28	0.46	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	6.42	9.09	1.07	0.27	0.27	1.87	4.01	1.60	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	8.87	4.90	0.31	0.46	0.77	1.38	1.99	1.22	1.07	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	10.88	1.81	1.30	0.26	0.39	1.17	1.55	1.17	0.39	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	4.34	7.59	0.27	0.27	0.54	0.81	5.69	1.08	1.08	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	16.22	8.30	2.03	0.74	1.47	2.40	2.21	1.47	1.84	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	14.04	8.33	3.51	0.22	0.22	3.73	2.19	1.54	2.41	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	14.88	29.75	0.00	0.00	0.00	1.98	11.90	0.00	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	15.30	5.28	3.83	0.79	1.32	3.17	1.71	1.32	2.77	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	19.77	6.05	3.23	1.41	1.41	3.03	2.22	1.01	2.42	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	24.65	32.28	1.78	2.54	2.29	0.76	15.25	0.00	0.00	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	0.80	0.20	0.40	4.98	20.30	0.60	0.20	1.39	0.20	1.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	0.31	0.00	1.08	3.54	14.02	0.77	0.00	0.92	0.15	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	0.82	0.00	0.61	4.50	32.73	1.43	0.00	0.82	0.41	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	1.88	0.00	0.00	2.82	9.70	0.00	0.00	1.88	0.63	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	0.28	0.00	0.57	2.54	11.02	0.00	0.00	1.13	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	0.00	0.00	0.00	5.07	35.97	0.92	0.00	0.92	0.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	7.42	0.00	2.47	4.95	24.75	2.47	0.00	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	1.93	0.39	2.32	4.25	22.82	2.32	0.00	0.77	1.55	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	1.60	1.60	1.60	3.21	20.86	3.21	0.00	0.00	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	3.48	0.00	0.00	6.96	12.17	0.00	0.00	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	4.23	0.33	2.60	1.30	16.60	2.28	0.00	2.60	1.63	1.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	2.06	0.41	4.94	4.12	21.41	5.35	0.41	2.06	1.24	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	3.33	0.00	3.33	3.33	16.66	3.33	0.00	10.00	3.33	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	7.83	1.12	1.68	1.40	14.54	3.64	0.00	0.84	1.68	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	4.58	0.65	1.96	3.27	16.34	4.58	0.00	1.63	1.31	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	5.03	0.00	0.84	4.19	13.42	2.52	0.00	5.03	0.84	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	10.18	0.32	1.59	3.18	14.63	4.13	0.00	1.91	0.64	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	8.15	0.00	0.34	2.38	8.15	5.43	0.00	1.36	2.72	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	4.18	0.00	2.09	4.18	10.44	0.00	0.00	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	12.60	2.86	1.15	3.44	10.31	7.45	0.00	1.72	1.15	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	6.51	0.30	0.30	2.07	4.14	6.51	0.00	2.96	1.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	15.25	6.78	1.69	1.69	10.16	3.39	0.00	0.00	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	8.28	0.41	4.14	2.49	9.53	7.46	0.00	2.49	0.83	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	12.66	1.15	3.22	2.99	12.20	4.37	0.92	3.22	0.69	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	0.00	0.00	0.00	5.27	5.27	0.00	0.00	10.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	9.23	3.08	1.92	3.84	9.23	5.00	0.77	2.69	2.69	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	6.52	4.56	2.28	2.61	5.22	3.26	0.98	3.59	2.28	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	5.35	4.68	0.67	0.67	5.35	0.67	1.34	0.67	0.00	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	12.33	6.55	2.31	4.24	8.48	3.47	2.70	3.47	4.62	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	14.72	2.40	3.42	0.34	9.24	4.45	0.68	4.45	2.40	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	0.00	2.48	4.97	2.48	2.48	2.48	0.00	9.94	4.97	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	15.10	4.72	4.72	2.83	3.30	7.08	1.42	3.77	4.72	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	9.66	5.43	1.21	2.41	6.03	10.26	0.00	5.43	4.22	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	13.23	8.65	3.05	4.07	6.10	3.05	2.03	0.00	2.03	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	11.97	6.38	5.98	3.99	5.58	5.18	1.20	6.38	2.79	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	11.35	11.84	0.49	2.47	3.95	10.36	2.96	2.96	1.97	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	12.98	8.26	3.54	3.54	4.72	12.98	2.36	1.18	2.36	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	9.92	4.67	2.33	1.75	9.34	11.09	1.17	2.92	2.92	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	10.53	8.34	1.76	2.63	3.95	5.71	2.63	1.76	1.76	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	20.34	6.78	3.39	6.78	8.48	14.41	0.85	9.32	9.32	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	11.34	4.18	3.58	1.19	2.39	10.15	0.60	5.97	3.58	2.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	10.19	6.31	1.46	3.88	6.31	10.68	2.91	4.85	2.91	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	1.14	0.00	1.14	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	4.16	1.25	1.66	0.00	0.00	5.41	2.08	0.42	1.25	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	2.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	6.98	4.12	0.00	0.95	0.00	2.22	3.81	1.59	1.59	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	5.85	2.09	0.00	0.00	0.00	1.67	2.92	0.00	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	6.85	1.39	2.20	0.58	0.00	1.97	1.51	1.51	0.93	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	5.40	1.52	3.04	0.51	0.00	2.03	1.35	0.34	0.68	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	4.55	1.59	1.37	0.68	0.00	1.59	0.68	1.59	0.91	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	5.57	1.64	1.75	0.33	0.00	2.51	1.31	0.87	0.55	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	5.59	1.07	2.15	0.43	0.00	1.07	0.43	1.29	0.64	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	3.44	0.00	1.29	0.65	0.00	0.65	0.65	0.00	0.86	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	3.24	1.25	1.87	0.62	0.00	1.87	0.62	0.62	0.62	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	3.60	0.69	1.37	0.00	0.00	0.86	0.34	1.03	0.17	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	3.20	0.32	1.28	0.64	0.00	0.96	0.64	0.64	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	13.43	3.36	0.00	2.80	1.68	0.00	1.68	1.12	0.00	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	14.28	3.03	0.87	1.30	0.87	0.87	1.30	0.43	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	5.29	0.00	0.00	2.64	0.00	5.29	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	16.93	9.17	1.41	0.35	0.35	0.35	1.76	2.12	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	18.16	6.54	2.18	0.73	0.00	0.00	0.00	0.73	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	19.41	3.32	1.22	0.70	0.35	2.80	1.92	5.25	4.55	0.52
Hepatocyte, donor1	11523-119I2	2.42	44.79	0.00	6.05	1.21	3.63	15.74	1.21	2.42	10.90
Hepatocyte, donor2	11603-120I1	2.15	18.31	1.08	8.62	0.00	14.01	10.77	4.31	5.39	5.39
Hepatocyte, donor3	11684-122I1	6.75	46.63	0.00	14.11	3.07	3.07	10.43	4.91	1.23	7.98
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	27.41	20.23	0.00	14.36	0.00	5.87	6.53	1.96	1.31	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	11.89	32.68	6.82	3.85	14.51	3.15	6.29	3.32	3.15	1.75
Iris Pigment Epithelial Cells, donor1	11530-119I9	13.86	5.63	2.74	0.27	1.92	2.74	1.65	2.88	1.51	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	6.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	6.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	2.77	1.38	2.77	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	0.00	0.00	0.00	0.00	0.00	2.50	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	23.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00	0.00	0.00	0.00	0.00	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	0.00	0.00	0.00	4.87	0.00	0.00	3.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	1.67	3.33	0.00	3.33	0.00	0.00	0.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	3.97	0.00	2.65	0.00	0.00	2.65	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	1.11	0.00	2.22	0.00	0.00	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	1.26	0.63	0.63	0.63	0.00	0.00	0.63	0.63	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	0.00	0.00	3.09	0.00	0.00	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	29.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.65	1.29	0.00	1.29	0.00	0.00	0.00	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	1.61	0.00	3.22	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	11.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	1.63	4.07	0.00	1.63	0.00	0.00	1.63	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	1.68	1.26	0.00	0.84	0.00	0.00	1.68	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	0.00	3.21	0.00	2.41	0.00	0.80	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	0.00	0.00	0.92	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.94	1.42	0.00	1.89	0.47	0.00	1.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.91	1.81	0.00	1.81	0.00	0.00	0.00	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	0.00	0.00	0.00	1.08	0.00	0.00	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	1.28	3.19	0.00	1.28	0.00	0.00	0.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	0.00	0.00	0.00	0.00	0.00	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.71	1.43	0.00	1.43	0.00	0.00	0.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	6.64	0.00	0.00	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.62	2.47	0.00	1.23	0.00	0.00	0.31	0.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	3.51	0.00	1.76	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	6.29	0.00	3.14	0.00	0.00	0.00	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	1.39	0.70	0.70	0.70	0.00	0.00	2.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	4.43	0.00	2.21	0.00	0.00	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	3.24	0.00	3.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.00	1.74	0.00	1.74	0.00	0.00	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	0.00	0.00	4.50	0.00	0.00	0.00	0.00	0.00	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	3.48	0.00	3.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	1.07	0.00	0.00	1.07	0.00	0.00	0.00	0.00	0.00	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	0.00	0.00	1.39	0.00	0.00	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	2.85	2.85	5.70	0.00	0.00	0.00	0.00	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.92	1.84	0.00	0.92	0.00	0.00	1.84	0.00	0.00	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	9.08	0.00	0.00	0.00	0.00	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	6.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	0.00	2.11	0.00	6.34	0.00	0.00	0.00	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	12.65	0.57	0.16	0.49	0.00	2.45	0.73	0.24	1.22	0.33
Keratinocyte - epidermal, donor2	11349-117G8	1.76	0.00	0.59	0.00	0.00	0.59	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	28.21	0.00	0.47	0.47	0.00	1.51	0.00	2.84	1.14	0.28
Keratinocyte - oral, donor1	11251-116E9	26.79	2.61	2.27	2.61	1.48	4.31	0.79	3.06	2.27	1.25
Keratocytes, donor1	11527-119I6	31.29	19.60	2.06	1.38	0.00	2.41	4.47	2.06	1.38	1.03
Keratocytes, donor2	11607-120I5	21.09	4.69	2.34	0.00	0.00	2.34	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	30.23	14.03	2.17	1.58	0.20	3.16	2.96	2.57	2.57	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	6.59	8.79	0.00	8.79	0.00	2.20	2.20	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	20.50	1.08	6.47	1.08	5.39	7.55	1.08	3.24	1.08	2.16
Lens Epithelial Cells, donor2	11609-120I7	22.26	1.96	2.54	1.85	3.69	4.15	1.15	2.65	2.19	0.81
Lens Epithelial Cells, donor3	11690-122I7	18.37	7.87	19.98	0.10	3.33	2.22	1.11	1.41	1.11	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	22.65	7.59	1.42	0.24	3.08	2.49	1.78	3.56	2.61	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	16.19	4.47	0.56	0.84	1.40	8.93	1.12	5.58	3.63	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	25.66	6.61	2.83	0.79	4.41	16.84	1.73	8.34	5.35	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	17.21	6.99	0.00	0.54	1.08	5.38	1.61	1.61	2.69	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	17.96	5.99	0.32	0.32	0.95	9.14	1.58	0.95	2.21	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	15.53	4.10	1.40	0.54	1.40	7.33	0.54	4.10	3.88	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	27.91	2.46	0.82	1.23	1.23	12.31	1.64	1.64	2.05	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	14.66	3.29	0.25	1.01	0.51	3.54	1.52	1.26	2.02	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	18.02	4.93	1.55	1.41	1.97	8.16	0.84	4.08	4.22	0.99
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	25.71	7.52	2.37	0.40	2.37	10.68	1.19	3.56	7.52	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	23.07	6.40	1.16	0.97	1.36	7.95	1.74	2.52	3.30	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	11.85	1.48	0.37	0.37	1.11	6.67	0.74	2.78	2.22	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	21.95	5.57	1.05	0.70	1.74	8.71	0.70	2.79	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	22.42	5.96	0.72	0.48	0.72	6.20	2.39	2.15	1.67	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	17.31	3.98	1.24	0.69	2.06	10.16	0.41	4.94	3.02	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	27.41	6.47	0.92	1.23	1.23	8.31	1.54	6.47	4.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	11.85	4.05	0.62	0.00	0.31	6.55	0.62	1.56	1.87	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	17.02	4.21	1.65	1.46	3.11	9.70	0.91	7.69	2.74	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	25.34	3.95	0.99	0.33	1.32	7.90	1.32	3.62	2.96	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	14.35	2.93	0.29	0.00	0.88	4.39	1.76	0.88	2.05	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	12.70	3.73	0.75	0.75	0.50	6.47	1.49	1.49	2.74	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	30.07	4.36	1.45	0.48	0.48	10.18	2.42	2.91	3.39	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	23.70	6.19	1.35	0.54	2.15	7.54	1.35	3.23	2.69	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	20.89	5.15	0.76	0.76	1.67	12.11	1.51	6.81	3.63	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	24.88	4.67	2.07	0.52	1.56	7.26	3.63	2.59	3.11	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	28.90	6.49	1.47	1.26	2.72	9.63	2.09	4.82	3.56	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	23.01	3.46	2.26	1.50	2.11	8.87	1.20	5.11	2.41	1.05
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	28.89	8.25	1.38	0.00	2.75	13.07	1.38	3.44	4.13	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	25.40	6.59	1.13	0.56	2.45	7.71	0.94	1.51	3.57	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	21.10	3.61	0.85	0.11	2.23	6.57	1.27	3.50	1.70	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	25.68	3.88	0.97	0.97	3.88	13.08	0.97	5.33	4.36	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	28.12	4.96	0.99	0.33	2.65	9.26	0.33	4.30	4.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	18.46	5.20	1.36	0.74	1.36	9.04	0.87	5.20	4.46	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	31.84	8.89	2.96	0.74	2.96	9.63	2.22	3.33	4.81	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	26.93	6.67	0.99	0.25	2.47	13.10	1.48	2.96	7.66	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	17.46	3.99	0.69	1.37	2.20	8.25	0.55	3.44	1.92	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	32.16	5.47	1.93	0.96	2.89	14.80	0.96	3.86	4.18	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	43.52	8.83	1.52	0.61	3.96	10.04	3.04	5.48	6.39	1.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	27.99	6.30	2.80	1.54	3.78	10.64	1.54	5.46	4.20	1.26
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	20.62	2.13	0.36	0.36	2.49	8.18	0.36	4.27	4.27	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	20.36	4.36	1.45	0.00	2.42	11.63	2.91	1.94	5.33	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	12.14	3.58	1.09	0.78	0.47	4.98	0.93	2.96	1.87	0.93
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	15.40	5.73	0.36	0.00	2.15	5.37	1.07	3.94	3.22	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	32.67	5.55	0.33	0.65	3.27	6.21	1.63	2.94	4.90	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	12.24	1.88	1.41	0.47	0.71	6.12	0.71	2.35	1.88	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	22.89	8.66	1.98	1.61	1.98	2.85	1.98	3.22	2.23	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	18.19	3.84	0.00	0.00	2.05	4.61	1.28	2.56	1.79	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	15.81	2.39	1.19	0.30	2.39	3.88	0.30	4.48	2.09	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	0.00	4.53	2.27	0.00	0.00	0.00	0.00	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	12.27	0.77	4.60	3.07	0.00	2.30	0.00	2.30	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	7.42	0.00	2.97	2.97	0.00	0.00	0.00	1.48	0.74	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	7.62	0.00	7.19	2.96	0.00	0.42	0.42	2.12	1.27	2.54
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.74	0.00	3.52	1.41	0.00	2.11	0.00	0.70	0.70	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	9.34	0.00	0.93	2.80	0.00	0.00	0.00	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.31	0.52	2.58	2.58	0.00	1.03	0.52	1.55	3.61	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	10.71	0.00	3.57	3.57	0.00	1.19	0.00	0.00	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	7.46	0.00	3.17	2.49	0.00	0.00	0.68	0.23	0.23	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	9.89	0.29	4.36	1.74	0.00	6.40	0.00	2.33	2.04	2.33
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	12.15	0.00	5.85	2.25	0.00	1.35	0.00	2.25	2.25	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	11.38	0.27	6.23	3.25	0.00	1.08	0.14	0.41	0.81	2.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	8.73	0.00	2.57	3.08	0.00	2.57	0.00	1.03	1.03	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	7.06	0.00	5.29	2.82	0.00	2.12	0.00	4.23	1.76	2.12
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	17.32	0.00	4.00	0.67	0.00	0.00	0.00	0.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	14.77	0.51	4.58	4.08	0.00	5.09	0.00	1.53	2.55	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	15.74	0.00	5.87	2.40	0.00	2.40	0.27	1.87	2.13	2.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	12.66	0.19	4.16	3.59	0.00	3.78	0.19	1.51	2.46	2.65
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	17.18	1.23	7.98	1.84	0.00	1.84	0.00	0.61	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	12.23	0.82	7.34	1.63	0.00	0.00	0.00	1.63	0.00	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	12.91	0.42	7.91	2.71	0.00	3.96	0.21	2.71	1.67	2.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	13.73	0.00	7.01	1.96	0.00	5.61	0.00	3.64	3.36	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	9.27	0.00	9.27	7.21	0.00	0.00	0.00	0.00	1.03	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	13.93	0.29	8.13	2.32	0.00	3.48	0.58	2.32	2.32	1.74
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	11.66	0.30	5.98	4.78	0.00	4.48	0.00	2.99	1.79	1.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	12.72	0.55	4.43	7.19	0.00	3.87	0.00	0.00	0.55	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	15.91	0.35	7.78	3.89	0.00	2.12	0.00	1.06	1.06	2.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	16.60	0.00	5.53	3.32	0.00	3.69	0.37	1.48	2.21	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	10.36	0.00	6.91	4.61	0.00	0.00	0.00	0.00	0.00	4.61
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	13.82	0.77	6.52	1.92	0.00	1.92	0.00	0.38	0.77	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	8.49	0.00	9.06	1.13	0.00	3.40	0.57	0.00	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	11.49	0.82	8.20	2.46	0.00	0.82	0.00	0.82	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	16.72	0.00	7.23	4.07	0.00	2.71	0.45	1.36	0.45	3.62
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	12.21	0.00	5.03	0.72	0.00	1.44	0.72	2.15	1.44	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	12.70	0.00	8.96	4.48	0.00	2.24	0.00	1.49	1.49	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	17.09	0.37	7.80	4.46	0.00	1.86	0.00	1.49	1.49	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	11.20	0.00	8.18	1.72	0.00	4.74	0.43	2.58	2.58	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.13	0.00	5.99	2.57	0.00	0.86	0.00	0.86	1.71	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	16.33	0.33	7.00	2.67	0.00	2.33	1.00	1.33	2.33	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	14.48	0.60	9.05	3.02	0.00	1.81	0.60	3.02	0.60	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	11.38	0.71	6.40	2.84	0.00	2.13	0.71	0.00	0.00	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	15.81	0.00	7.22	5.50	0.00	2.06	0.00	2.41	0.34	2.06
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	11.27	0.00	10.73	2.68	0.00	2.15	0.00	1.61	2.68	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	10.77	0.00	10.77	4.04	0.00	0.67	0.00	0.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	11.85	0.37	8.89	3.33	0.00	1.11	0.00	2.96	2.96	1.48
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	3.49	0.00	6.98	5.81	0.00	0.00	0.00	0.00	1.16	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	5.29	0.00	5.29	7.40	0.00	2.12	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	14.81	0.40	7.20	1.60	0.40	1.20	0.80	2.00	1.60	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	11.63	0.00	5.09	3.63	0.00	0.00	0.73	0.00	0.73	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	10.73	0.00	8.43	4.60	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	9.37	0.00	5.92	3.95	0.00	0.99	0.00	0.49	0.49	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	6.59	0.00	6.59	1.88	0.00	0.94	0.94	1.88	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	9.55	1.51	5.03	3.02	0.00	0.00	0.50	3.02	0.50	3.52
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	11.72	0.45	4.06	0.45	0.00	0.45	0.00	0.45	1.35	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	12.05	1.72	1.72	5.16	0.00	0.00	0.00	0.00	0.00	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	8.91	0.00	2.67	4.90	0.00	0.45	0.45	0.45	1.34	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	14.08	0.00	7.43	3.91	0.39	2.74	0.00	0.39	0.78	1.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	11.22	0.00	5.28	5.28	0.00	1.32	0.00	1.32	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	9.86	0.00	6.75	4.67	0.00	0.00	0.00	1.56	0.52	2.59
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	11.38	0.00	5.69	4.81	0.00	0.44	0.00	1.75	1.31	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	7.27	0.56	3.35	2.24	0.00	4.47	0.56	0.56	1.68	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	8.39	0.00	5.74	4.42	0.00	3.09	0.00	2.21	1.32	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	13.50	0.39	6.17	3.86	0.00	1.93	0.77	1.54	1.16	1.93
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	11.65	0.00	5.06	2.53	0.00	4.05	0.51	0.51	0.51	3.04
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	11.53	0.00	4.33	1.44	0.00	4.33	0.00	2.88	0.96	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	13.91	0.40	9.54	3.58	0.00	1.59	0.00	0.80	1.59	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	10.33	0.00	6.08	2.43	0.61	1.82	0.00	2.43	0.00	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	13.14	0.69	2.77	2.08	0.00	0.69	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	14.82	0.00	7.98	4.18	0.00	2.28	0.00	1.14	2.66	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	10.33	0.00	6.71	3.10	0.00	1.55	0.00	1.03	0.00	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	13.30	0.00	4.84	6.05	0.00	1.21	0.00	1.81	0.60	2.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	20.28	0.00	5.70	4.75	0.32	3.17	0.00	0.95	1.58	3.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	14.93	0.53	5.33	2.13	0.00	0.53	0.53	0.53	1.07	2.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	11.49	1.15	6.32	2.30	0.00	0.00	0.00	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	13.37	0.00	6.69	5.14	0.00	1.54	0.51	1.03	1.03	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	11.32	0.00	7.07	2.12	0.00	0.00	0.00	0.71	0.71	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	7.38	0.00	4.54	3.40	0.00	0.57	0.00	1.70	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	14.14	0.42	9.57	2.91	0.42	1.66	0.00	1.25	1.66	2.50
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	15.66	0.00	5.48	1.57	0.00	1.57	0.00	0.78	1.57	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	6.26	0.00	8.35	2.09	0.00	0.84	0.00	0.00	0.00	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	13.94	0.46	8.36	3.72	0.00	1.39	0.46	0.93	0.00	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	20.74	0.00	8.03	2.01	0.00	2.01	0.00	0.00	0.67	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	10.69	0.00	8.02	4.28	0.00	1.60	0.00	0.53	1.07	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	18.59	0.00	9.70	1.62	0.40	0.81	0.00	2.42	0.40	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	10.10	0.00	5.51	2.75	0.00	2.75	0.00	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.00	0.00	6.22	0.00	0.00	0.89	0.00	0.89	0.89	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	18.24	0.57	7.98	2.85	0.00	1.14	0.00	1.14	3.42	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	8.44	0.00	11.50	2.30	0.00	2.30	0.00	0.00	1.53	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	12.04	0.00	6.02	2.74	0.00	1.09	0.00	0.00	0.55	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.03	0.00	5.79	4.45	0.00	0.89	0.00	0.45	0.00	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	11.96	0.00	5.98	3.38	0.00	0.52	0.00	0.26	0.00	2.08
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	8.62	0.00	5.97	3.32	0.00	0.00	0.00	0.00	0.66	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	16.63	0.00	4.16	6.24	0.00	0.00	0.00	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	9.12	10.94	0.46	3.87	0.00	1.14	3.65	1.37	1.82	1.60
Macrophage - monocyte derived, donor2	11313-117C8	4.40	3.67	0.00	1.10	0.00	0.73	0.55	0.92	0.18	0.55
Macrophage - monocyte derived, donor3	11389-118C3	8.78	4.98	0.13	2.36	0.00	0.66	1.84	1.70	0.52	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	5.84	0.00	1.59	0.00	0.00	0.53	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	16.32	2.06	3.33	0.32	0.79	1.27	0.95	0.48	0.48	0.00
Mallassez-derived cells, donor3	11930-125I4	17.65	0.69	1.11	1.39	0.69	1.67	0.42	1.67	0.83	0.14
Mammary Epithelial Cell, donor1	11273-116H4	14.25	0.70	1.99	2.49	0.40	4.88	0.40	4.98	1.59	1.30
Mammary Epithelial Cell, donor2	11350-117G9	23.74	0.87	3.76	2.03	0.29	2.03	1.16	2.03	0.58	0.87
Mammary Epithelial Cell, donor3	11422-118F9	18.46	0.25	1.25	0.00	0.25	0.75	0.00	1.00	1.25	0.00
Mast cell - stimulated, donor1	11487-119E2	159.32	1237.91	3.39	4.75	5.42	1.36	157.96	0.00	2.03	4.07
Mast cell, donor1	11563-120D6	8.33	85.11	2.49	6.70	1.08	9.30	14.17	7.79	5.41	2.16
Mast cell, donor2	11565-120D8	36.55	74.89	10.40	11.29	0.89	13.08	20.21	11.59	8.32	3.86
Mast cell, donor3	11566-120D9	62.13	55.38	11.48	12.38	0.90	18.46	16.21	17.11	10.36	4.28
Mast cell, donor4	11567-120E1	23.76	69.50	8.51	9.40	0.18	13.47	10.81	12.41	8.86	3.72
Mast cell, expanded and stimulated, donor5	11940-126A5	23.40	153.36	2.99	2.77	1.89	6.76	27.95	6.88	5.99	1.44
Mast cell, expanded and stimulated, donor8	11942-126A7	23.93	126.08	2.33	0.58	2.92	8.76	17.51	3.50	6.42	0.00
Mast cell, expanded, donor5	11939-126A4	10.55	44.05	2.52	2.41	0.57	4.47	9.64	3.90	3.44	1.26
Mast cell, expanded, donor8	11941-126A6	18.24	189.46	4.52	4.52	1.67	7.87	27.95	10.04	12.39	3.18
Melanocyte - dark, donor1	11502-119F8	48.06	6.96	1.29	1.99	2.69	5.17	0.99	6.67	4.18	1.09
Melanocyte - dark, donor2	11582-120F7	16.61	9.34	2.42	0.00	0.00	6.58	4.15	2.08	4.85	0.00
Melanocyte - dark, donor3	11663-122F7	4.78	6.01	0.00	0.22	0.00	0.65	2.39	1.59	0.58	0.00
Melanocyte - light, donor1	11274-116H5	1.18	3.53	0.00	0.00	0.00	0.24	2.12	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	1.36	2.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.68
Melanocyte - light, donor3	11423-118G1	3.47	0.00	0.00	0.87	0.00	0.00	0.00	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	4.37	1.56	0.00	0.10	0.00	0.42	1.67	0.31	0.21	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	0.27	0.27	0.00	0.00	0.00	0.27	0.54	0.00	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	1.61	4.82	0.00	0.27	0.00	0.27	2.68	0.54	0.27	0.00
Meningeal Cells, donor1	11493-119E8	38.71	15.88	1.61	1.74	1.24	1.61	2.73	2.36	0.12	1.24
Meningeal Cells, donor2	11573-120E7	26.41	5.72	6.60	3.08	0.88	1.32	1.76	3.96	0.44	3.08
Meningeal Cells, donor3	11654-122E7	52.08	17.85	1.79	0.90	1.87	5.46	2.61	2.45	3.59	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	23.67	21.96	1.43	0.57	1.14	3.14	3.14	6.27	4.56	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	16.20	16.91	9.26	0.40	1.31	7.04	3.42	2.01	2.31	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	0.00	0.00	0.00	0.00	0.00	2.63	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	10.47	1.31	0.00	0.00	0.00	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	12.92	3.59	0.72	0.72	0.00	0.72	2.15	1.44	1.44	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	11.65	5.08	8.26	0.21	0.00	1.91	0.85	1.48	1.27	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	7.04	4.52	3.02	1.01	0.00	5.53	0.00	3.52	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	12.31	8.35	0.66	0.22	0.00	1.32	3.74	0.44	0.88	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	19.73	13.15	0.73	0.00	0.73	1.46	3.65	2.92	2.19	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	19.03	7.57	0.20	0.00	0.20	1.23	2.66	1.23	0.82	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	10.94	5.54	0.28	0.28	0.28	2.22	2.77	0.97	0.28	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	2.97	4.46	1.49	0.00	0.00	0.37	4.09	0.00	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	10.66	18.95	0.39	0.92	0.39	1.05	3.55	1.32	1.71	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	3.56	2.97	0.00	0.00	0.00	0.30	0.89	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	1.92	3.20	0.00	0.64	0.64	0.00	1.92	1.28	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	16.66	5.32	0.00	0.00	0.00	1.77	2.13	1.42	2.13	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	5.00	9.38	0.00	1.56	0.00	2.19	2.50	0.94	2.19	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	2.18	2.18	0.00	0.00	0.00	0.73	0.73	0.73	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	5.57	0.27	1.33	1.06	0.00	1.59	0.27	1.06	0.80	0.00
Mesothelial Cells, donor2	12156-128G5	0.50	0.00	0.00	0.50	0.00	0.50	0.00	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	7.37	0.65	4.41	0.87	0.22	2.02	0.29	1.81	1.52	0.51
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	9.45	8.10	0.00	0.00	0.00	2.70	2.70	1.35	0.00	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	7.14	9.11	0.74	0.99	0.00	3.45	2.46	1.23	0.00	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	7.07	6.77	0.00	0.00	0.00	1.77	2.06	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	5.58	4.65	0.00	0.62	0.00	2.17	1.55	0.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	4.77	3.73	0.21	0.62	0.00	0.62	0.41	0.83	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	0.00	4.63	0.00	0.00	0.00	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	6.76	7.76	0.25	1.75	0.00	0.75	1.50	0.00	1.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	8.38	2.79	0.00	1.40	0.00	0.47	2.33	0.47	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	3.86	5.08	0.00	0.61	0.00	1.63	1.22	1.42	0.41	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	9.50	4.36	0.40	0.79	0.00	0.00	0.79	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	0.00	17.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	13.27	3.54	0.00	0.00	0.00	0.00	0.88	0.88	3.54	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	7.60	2.66	0.00	0.00	0.00	0.38	1.14	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	9.21	0.00	0.00	1.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	8.49	4.03	0.00	1.49	0.00	2.12	1.06	1.70	1.27	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	6.45	0.92	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	11.03	2.68	0.60	0.30	0.00	1.49	0.30	0.60	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	13.80	3.01	0.75	1.25	0.25	2.26	1.00	2.01	1.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	5.23	1.90	0.48	0.48	0.00	1.66	0.48	0.71	0.71	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	21.56	0.00	1.66	1.66	0.00	2.21	1.11	1.11	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	12.66	3.22	1.84	1.15	0.00	2.07	0.69	1.84	0.46	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	9.25	1.68	0.42	0.21	0.00	0.00	0.63	0.42	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	23.03	1.63	5.10	0.61	0.00	0.41	0.00	0.82	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	12.87	4.08	0.86	0.21	0.00	2.36	1.29	1.07	1.29	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	10.67	0.89	0.22	0.22	0.00	0.44	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	22.56	1.10	1.75	0.44	0.00	2.41	0.44	1.10	0.88	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	6.59	0.51	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	29.83	0.00	3.31	0.00	0.00	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	26.36	1.09	3.53	0.54	0.00	1.90	0.54	0.54	1.36	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	7.06	1.47	0.88	0.29	0.00	0.59	0.29	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	17.45	0.00	9.81	0.00	0.00	0.00	0.00	0.00	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	17.30	1.92	3.36	0.48	0.00	4.81	0.00	3.36	1.92	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	8.40	1.20	4.80	0.80	0.00	1.20	0.80	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	17.83	0.00	9.60	1.37	0.00	2.74	0.00	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	23.53	0.50	5.51	0.00	0.00	2.00	0.00	1.00	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	24.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	14.89	0.44	6.13	0.00	0.00	3.50	0.44	0.88	1.75	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	0.00	3.31	0.00	0.00	1.10	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	17.93	0.00	7.04	0.64	0.00	0.00	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.14	0.50	3.72	0.50	0.00	2.73	0.00	0.99	1.24	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.78	0.00	2.09	0.00	0.00	0.00	0.00	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	0.00	4.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5.81	1.03	2.74	0.00	0.00	1.03	0.34	2.05	1.03	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1.75	0.88	1.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	5.68	0.36	2.84	1.42	0.00	0.36	0.00	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	4.77	0.28	5.61	0.28	0.00	1.40	0.56	1.40	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1.25	0.00	1.66	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	6.99	1.17	5.83	1.17	0.00	0.00	0.00	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	4.52	0.30	3.92	0.30	0.00	1.51	0.00	1.21	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	1.67	0.42	0.83	0.42	0.00	0.00	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	3.69	0.00	3.69	0.00	0.00	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	5.12	2.85	0.57	0.00	0.00	0.00	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	5.25	1.80	2.49	0.28	0.14	0.00	1.24	0.28	0.00	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	2.59	1.30	2.07	0.26	0.00	1.04	0.26	0.00	1.04	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	1.29	1.29	1.29	0.00	0.00	0.43	0.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	2.54	0.64	6.35	0.64	0.00	0.00	1.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	4.27	1.87	7.74	0.00	0.00	0.80	0.27	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	2.69	4.49	1.50	0.60	0.00	0.90	1.80	0.30	0.60	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	7.20	3.25	1.55	0.42	0.00	0.00	2.26	0.00	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	4.14	1.27	1.91	0.00	0.00	0.64	0.96	0.96	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	2.43	1.77	0.88	0.44	0.00	0.44	0.44	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	6.07	2.28	3.79	0.00	0.00	0.00	1.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	3.98	3.41	4.83	0.28	0.00	2.56	1.70	0.57	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	1.23	1.72	0.49	0.49	0.00	0.25	0.25	0.74	0.00	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	11.73	3.26	0.65	2.61	0.00	1.30	1.96	1.96	1.30	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	5.88	7.06	0.59	0.59	0.00	0.88	2.65	0.88	0.88	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	5.48	5.19	0.00	1.73	0.00	0.58	0.29	0.86	0.00	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	9.07	14.84	0.00	0.82	0.00	2.89	6.18	0.00	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	5.96	6.55	0.89	0.60	0.00	0.60	2.38	0.30	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	3.77	0.00	3.77	0.00	0.00	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	3.56	0.00	0.00	0.00	1.78	3.56	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	7.23	6.90	0.00	0.33	0.00	1.64	2.30	2.30	0.33	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	2.10	5.26	0.00	3.16	0.00	4.21	5.26	1.05	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	5.34	12.26	0.00	0.00	0.00	0.40	2.97	1.78	0.79	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	12.11	7.45	0.00	1.86	0.00	0.93	1.86	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	14.27	10.14	0.00	0.00	0.00	5.26	1.13	4.13	2.63	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	4.53	3.73	0.00	0.53	0.27	1.33	0.80	0.80	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	4.30	5.32	0.00	0.90	0.00	0.11	1.36	0.57	0.23	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	7.37	2.95	0.74	0.74	0.00	0.74	0.74	1.47	0.00	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	12.09	8.79	0.00	0.73	0.00	2.56	2.93	0.73	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	7.78	4.67	0.00	1.56	0.00	1.56	1.56	3.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.41	2.14	0.00	0.53	0.00	0.00	1.07	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	7.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	11.11	6.06	0.00	1.01	0.00	1.01	1.01	1.01	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	5.48	1.69	0.42	0.84	0.00	1.26	0.84	0.84	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1.36	6.81	1.36	1.36	0.00	0.00	1.36	0.00	0.00	4.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	7.63	0.64	0.00	0.00	0.00	0.00	0.64	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	8.91	1.62	3.24	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	7.55	0.00	3.02	0.00	0.00	1.51	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	22.84	17.13	5.71	0.00	0.00	0.00	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	32.62	6.52	13.05	0.00	0.00	3.26	0.00	0.00	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	4.75	4.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55	0.00	12.55	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	23.27	3.88	3.88	0.22	0.65	2.59	0.22	0.86	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	59.58	3.66	15.16	1.05	1.57	5.23	2.09	6.79	5.23	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	72.09	0.67	12.01	0.00	0.67	0.67	2.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	80.55	1.25	7.51	1.25	0.83	0.83	1.25	1.67	3.34	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	26.24	2.66	16.73	1.33	0.76	0.95	2.09	2.47	1.90	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	170.76	4.79	9.58	0.00	0.00	1.60	1.60	1.60	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	50.32	2.04	9.52	0.00	0.00	3.40	2.04	0.00	1.36	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	5.51	3.68	3.68	0.00	0.00	1.84	3.68	34.92	31.24	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	31.39	2.09	9.21	0.42	0.42	0.00	0.00	2.09	1.26	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	33.47	2.79	5.35	0.70	0.70	0.70	2.09	1.16	0.93	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	39.99	0.81	20.54	0.81	0.00	1.62	0.54	0.54	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	42.89	3.57	18.50	0.42	0.84	10.09	1.68	2.73	1.05	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	22.27	11.13	0.00	0.00	11.13	0.00	100.21	144.75	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	28.29	2.98	10.92	0.00	0.00	1.49	0.99	1.49	1.49	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	14.89	1.89	5.95	0.00	0.27	0.81	2.17	1.35	1.35	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	23.80	3.17	2.95	0.45	0.45	0.91	2.27	1.13	0.23	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	33.15	1.31	14.21	0.33	0.33	0.16	0.65	0.82	0.82	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	34.45	2.37	13.49	1.46	0.55	6.74	2.73	2.37	1.46	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	30.23	2.65	8.49	1.06	0.00	2.12	2.12	3.18	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	33.02	1.20	4.20	0.00	0.00	0.60	3.60	0.60	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	5.25	7.22	8.86	1.64	0.00	1.64	4.92	3.61	2.30	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	22.60	2.28	5.85	0.98	0.33	0.16	1.79	0.81	1.14	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	50.27	6.35	10.58	0.88	0.35	6.35	3.88	2.82	0.71	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	28.83	4.22	8.44	0.70	0.00	1.41	0.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	34.02	0.46	4.14	1.38	0.00	1.84	2.30	1.38	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	31.17	1.93	10.28	0.32	0.32	2.25	2.25	0.00	0.96	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	6.21	10.00	3.45	1.03	1.03	1.03	4.83	3.45	2.76	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	15.17	7.59	2.53	2.53	0.00	0.00	0.00	12.64	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	43.00	5.12	5.79	0.45	0.45	2.90	3.79	1.34	0.89	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	16.94	2.54	8.47	0.00	0.00	1.69	1.27	1.69	0.85	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	22.79	4.27	3.09	2.85	0.47	0.71	3.32	0.71	0.47	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	39.49	1.72	12.88	1.29	0.00	0.43	1.72	0.43	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	18.06	0.00	0.00	9.03	0.00	36.11	45.14	63.19	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	34.32	2.67	12.33	1.00	0.00	1.00	1.33	0.67	0.33	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	40.13	2.25	13.08	0.45	0.90	1.35	2.71	0.90	0.45	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	16.67	2.38	8.33	1.19	0.00	0.79	1.19	1.19	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	49.22	2.79	3.71	0.00	0.93	2.79	1.86	0.93	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	28.00	1.89	8.32	1.14	0.76	0.76	2.65	2.27	1.51	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	23.79	2.61	7.50	1.30	0.00	1.30	1.30	0.65	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	41.40	1.31	10.02	3.05	0.00	1.31	2.18	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	30.30	1.81	11.76	1.81	0.90	4.98	1.81	2.26	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	14.11	2.65	10.58	0.88	0.00	0.88	2.65	3.53	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	35.24	1.99	1.99	0.66	0.00	3.32	5.98	1.99	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	33.73	0.99	9.42	0.99	0.50	1.49	1.49	0.50	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	27.56	1.15	3.06	0.77	1.15	0.77	1.15	1.53	1.15	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	14.82	3.33	12.40	2.72	0.30	1.21	1.51	0.60	0.91	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	22.99	2.65	15.47	1.99	1.55	8.18	0.00	3.54	1.11	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	18.97	2.71	4.07	0.00	0.00	2.71	2.71	3.39	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	5.11	0.00	0.00	0.00	0.00	5.11	35.77	35.77	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	34.14	1.22	9.75	1.83	0.00	0.61	1.22	0.00	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.33	1.26	7.24	3.15	0.31	0.94	0.63	1.26	1.57	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	36.32	2.72	15.13	0.61	0.30	0.91	2.72	3.03	0.00	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	19.78	0.79	8.70	0.79	0.79	2.37	0.79	0.00	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	6.80	12.47	7.94	4.53	0.00	0.00	4.53	1.13	5.67	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	30.35	0.00	0.00	0.00	0.00	0.00	15.17	35.41	0.00
Myoblast, donor1	11241-116D8	8.45	4.35	0.12	0.25	0.00	0.50	1.24	0.50	0.25	0.37
Myoblast, donor2	11322-117D8	25.51	5.95	1.15	1.15	0.38	3.26	4.22	2.69	2.88	0.38
Myoblast, donor3	11398-118D3	12.61	3.36	2.02	0.17	0.34	1.18	3.53	1.01	1.01	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	5.25	43.78	0.00	1.61	0.00	4.82	6.57	4.38	1.46	0.15
Natural Killer Cells, donor1	11230-116C6	47.05	97.18	1.23	2.46	24.60	15.68	18.14	7.38	7.69	1.23
Natural Killer Cells, donor2	11311-117C6	83.23	60.91	0.00	1.21	20.51	31.36	17.19	9.95	10.25	1.51
Natural Killer Cells, donor3	11387-118C1	68.84	70.31	0.37	0.92	11.96	15.64	15.64	19.14	9.75	0.92
Neural stem cells, donor1	11275-116H6	10.89	8.35	0.00	2.18	0.00	1.45	2.90	0.36	0.36	0.36
Neural stem cells, donor2	11352-117H2	26.96	1.93	1.93	1.93	0.00	0.00	0.00	0.00	0.00	1.93
Neurons, donor1	11494-119E9	5.69	0.00	2.28	2.28	0.00	1.14	1.14	1.14	1.14	0.00
Neurons, donor2	11574-120E8	12.55	1.98	0.66	1.10	0.22	0.44	0.22	0.88	0.66	0.22
Neurons, donor3	11655-122E8	13.98	2.47	0.82	0.82	0.82	0.82	0.00	1.64	1.64	0.82
Neutrophils, donor1	11233-116C9	8.35	19.49	3.71	12.06	0.93	1.86	2.78	1.86	0.93	4.64
Neutrophils, donor2	11314-117C9	0.00	26.09	5.80	5.80	0.00	14.49	0.00	5.80	11.60	8.70
Neutrophils, donor3	11390-118C4	17.71	83.69	11.00	25.66	3.67	0.61	24.43	1.22	1.83	17.71
Nucleus Pulposus Cell, donor1	11252-116F1	40.73	40.96	2.37	2.26	0.83	10.21	13.77	5.94	5.94	1.31
Nucleus Pulposus Cell, donor2	11409-118E5	29.30	13.68	0.00	0.98	0.33	2.93	6.19	5.21	5.21	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	21.06	8.02	0.00	0.80	0.20	3.61	3.21	5.01	2.21	0.40
Olfactory epithelial cells, donor1	11933-125I7	33.59	4.82	3.03	1.38	0.00	7.30	2.20	4.54	3.72	0.69
Olfactory epithelial cells, donor2	11934-125I8	31.41	3.76	3.47	0.72	0.00	7.53	2.75	4.92	5.07	0.29
Olfactory epithelial cells, donor3	11935-125I9	34.28	3.75	3.52	0.91	0.00	7.72	2.16	3.41	4.88	0.57
Olfactory epithelial cells, donor4	11936-126A1	44.22	4.09	1.95	2.92	0.00	4.58	2.92	2.24	1.17	1.17
Oligodendrocyte - precursors, donor1	11496-119F2	14.44	9.03	2.41	0.00	0.00	1.81	3.61	6.62	3.01	1.81
Osteoblast - differentiated, donor1	11276-116H7	11.27	7.02	1.70	0.85	0.00	1.28	2.13	0.64	0.85	0.21
Osteoblast - differentiated, donor2	11353-117H3	8.00	1.14	3.43	1.14	0.00	1.14	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	13.03	3.72	0.62	0.62	0.00	1.24	3.10	1.86	0.62	0.00
Osteoblast, donor1	11277-116H8	11.92	4.89	14.85	0.39	0.39	2.35	1.76	1.95	0.98	0.00
Osteoblast, donor2	11354-117H4	40.73	14.05	17.56	2.11	0.00	6.32	2.81	4.92	0.70	0.70
Osteoblast, donor3	11426-118G4	31.28	4.44	24.35	0.53	1.24	0.89	1.07	1.42	1.07	0.18
Pancreatic stromal cells, donor1	11249-116E7	18.87	3.62	0.00	0.25	0.00	1.60	2.95	1.77	2.53	0.00
Pericytes, donor1	11491-119E6	11.68	7.79	0.22	0.45	0.00	0.89	2.11	1.45	0.00	0.00
Pericytes, donor2	11571-120E5	11.09	3.17	1.13	2.04	0.68	1.13	1.58	1.58	0.45	0.45
Pericytes, donor3	11652-122E5	17.50	6.10	1.63	0.41	0.41	2.03	1.83	1.63	1.42	0.00
Perineurial Cells, donor1	11499-119F5	27.92	9.49	1.13	1.02	2.15	4.63	2.37	2.60	2.37	0.45
Perineurial Cells, donor2	11579-120F4	21.35	15.73	2.48	1.10	1.20	0.74	4.42	2.12	2.12	1.10
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	77.45	106.14	8.61	6.06	76.18	14.98	11.16	5.42	7.65	3.19
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	58.77	43.34	7.84	5.88	47.99	21.79	5.39	12.00	10.04	5.63
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	56.30	50.47	6.99	3.24	32.48	5.31	8.02	6.73	2.98	2.59
Placental Epithelial Cells, donor1	11278-116H9	3.11	0.00	7.41	0.48	0.00	0.72	0.00	0.96	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	3.33	1.11	3.33	0.00	0.00	0.00	0.00	1.11	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	2.55	0.39	8.44	0.59	0.00	0.39	0.39	0.20	0.20	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.86	2.53	6.01	0.63	0.00	1.27	0.00	1.27	0.63	0.32
Preadipocyte - breast, donor1	11467-119B9	19.70	10.69	8.25	0.75	0.38	8.25	3.00	1.13	1.31	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	14.88	6.27	17.88	1.17	0.26	1.96	2.74	2.09	1.04	1.04
Preadipocyte - breast, donor2	11328-117E5	19.36	3.15	5.18	0.68	0.45	6.53	2.93	2.93	1.80	0.23
Preadipocyte - omental, donor1	11468-119C1	18.54	9.59	4.05	1.07	0.00	3.84	5.11	1.39	3.62	0.53
Preadipocyte - omental, donor2	11329-117E6	17.90	12.66	9.60	1.31	0.00	1.31	2.18	0.87	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	23.49	6.59	10.17	0.57	0.29	4.73	1.43	6.16	2.72	0.43
Preadipocyte - perirenal, donor1	11469-119C2	3.94	0.00	1.97	0.00	0.98	0.98	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	21.81	7.06	0.92	0.31	0.61	0.31	1.54	1.23	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	65.70	4.25	4.07	0.35	0.18	13.63	2.66	6.55	6.02	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	43.42	3.07	3.92	0.51	0.68	4.60	1.70	2.55	1.36	0.34
Preadipocyte - visceral, donor1	11280-116I2	72.19	8.10	0.75	0.28	0.56	11.18	3.26	5.87	4.01	0.19
Preadipocyte - visceral, donor2	11357-117H7	45.10	8.28	1.38	0.00	0.46	7.82	3.22	2.76	2.30	0.46
Preadipocyte - visceral, donor3	11429-118G7	39.71	3.24	0.73	0.21	0.10	9.82	1.99	5.33	1.78	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	8.75	18.10	3.62	1.51	8.60	1.81	2.87	2.41	1.36	0.30
Prostate Epithelial Cells, donor2	11331-117E8	7.31	0.14	1.22	1.49	0.14	2.44	0.14	1.35	0.27	0.27
Prostate Epithelial Cells, donor3	11404-118D9	9.12	0.18	0.55	7.78	0.06	1.84	0.18	3.49	1.65	1.96
Prostate Stromal Cells, donor1	11254-116F3	21.41	10.14	0.91	0.46	1.59	3.08	2.16	1.94	1.37	0.11
Prostate Stromal Cells, donor2	11332-117E9	25.28	7.35	2.15	0.54	0.18	6.81	3.59	3.59	2.15	0.18
Prostate Stromal Cells, donor3	11405-118E1	17.41	5.42	5.94	0.31	1.36	2.92	2.50	3.23	1.77	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	4.38	3.28	1.82	2.19	0.73	2.19	0.00	0.73	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	10.47	6.86	4.16	2.22	3.81	2.91	1.52	1.73	2.01	1.25
Renal Epithelial Cells, donor1	11517-119H5	9.13	5.58	6.59	0.51	2.54	0.00	0.51	1.01	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	13.52	2.85	4.27	1.42	2.13	1.42	0.71	0.71	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	22.23	8.26	8.15	2.43	3.60	4.55	2.12	3.92	3.71	1.27
Renal Glomerular Endothelial Cells, donor1	11514-119H2	1.36	2.04	0.68	0.68	0.00	1.36	2.04	0.00	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	8.49	2.83	0.00	1.48	0.13	2.02	0.94	1.21	0.40	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	20.87	9.99	6.88	0.67	0.67	2.22	2.44	2.66	2.22	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	8.65	5.32	2.00	1.33	0.67	0.00	0.67	0.00	0.00	2.00
Renal Mesangial Cells, donor1	11518-119H6	12.10	6.60	5.50	1.98	0.00	1.32	1.10	1.10	1.32	0.22
Renal Mesangial Cells, donor2	11598-120H5	22.57	1.25	13.17	0.00	0.00	1.25	0.63	0.63	2.51	0.00
Renal Mesangial Cells, donor3	11679-122H5	6.94	3.05	7.49	0.83	0.55	1.39	1.39	0.83	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	7.52	3.22	0.54	1.88	0.00	0.81	1.34	0.54	0.27	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	4.64	0.84	0.42	2.95	0.00	0.00	0.42	0.00	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	11.76	4.44	7.33	1.16	1.54	2.12	2.31	0.77	0.96	1.16
Retinal Pigment Epithelial Cells, donor0	11215-116A9	5.19	0.00	0.00	1.30	0.26	2.33	0.00	0.78	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	3.98	0.57	3.41	0.28	1.14	0.57	0.85	1.42	0.57	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	7.20	0.00	0.00	1.03	0.00	0.00	0.00	2.06	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	7.78	1.76	1.25	2.26	0.75	1.76	0.00	0.50	0.75	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	17.24	49.98	0.80	16.84	1.34	4.68	9.22	4.41	3.74	6.82
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	0.00	0.89	0.00	0.00	0.00	1.79	0.00	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	1.10	6.05	0.00	0.55	0.00	0.55	2.75	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	0.00	3.48	0.00	1.74	0.00	0.00	4.06	0.00	0.00	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	2.73	2.60	0.39	0.78	0.00	0.00	1.30	0.65	0.00	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	3.57	1.59	0.99	0.89	0.00	0.79	0.99	0.40	0.10	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	3.46	2.23	0.22	0.78	0.00	0.33	1.90	0.45	0.56	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	1.74	3.72	0.50	0.74	0.00	0.74	1.74	0.99	0.50	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	3.38	2.80	0.70	0.93	0.00	0.70	1.17	0.35	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	3.47	3.24	0.69	2.31	0.00	1.16	0.69	0.23	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	3.15	1.10	0.82	0.82	0.00	0.14	1.10	0.55	0.14	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	3.18	2.72	0.00	0.91	0.00	0.76	2.57	0.30	0.30	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	2.69	2.51	0.00	1.97	0.00	0.54	1.08	0.00	0.36	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	2.15	1.29	0.86	0.86	0.00	0.29	1.29	1.00	0.14	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	3.33	3.22	0.54	0.54	0.00	0.43	1.93	0.43	0.32	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	1.77	3.32	0.89	1.77	0.00	0.89	1.77	0.22	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	2.10	1.91	0.96	0.38	0.00	0.19	0.38	0.19	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	3.73	2.33	0.56	1.02	0.00	0.19	1.77	0.09	0.19	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	3.76	4.51	0.38	1.32	0.00	0.56	1.69	0.00	0.75	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	3.18	2.26	1.99	1.59	0.00	0.00	1.59	0.27	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	3.80	1.75	0.68	1.36	0.00	0.49	2.34	0.39	0.10	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	2.86	2.67	1.15	1.34	0.00	0.76	1.15	0.00	0.57	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	2.67	1.92	1.28	1.39	0.00	0.32	0.85	0.32	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	1.68	3.08	0.84	0.28	0.00	1.12	1.12	0.00	0.56	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	2.56	1.71	0.85	1.03	0.00	0.68	1.54	0.34	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	2.37	2.19	1.64	1.46	0.00	0.00	1.64	0.36	0.36	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	4.29	2.33	0.74	1.23	0.00	0.37	1.59	0.25	0.25	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	2.96	2.01	0.00	0.54	0.00	0.54	0.54	0.13	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	3.07	2.59	0.71	1.18	0.00	0.71	0.24	0.47	0.24	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	4.17	2.38	0.40	0.60	0.00	0.40	1.79	0.60	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	3.98	3.27	0.47	0.23	0.00	0.47	1.64	0.47	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	2.07	0.83	0.41	0.83	0.00	0.62	0.83	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	5.31	4.42	0.44	1.33	0.00	0.44	1.55	0.22	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	2.51	0.84	0.42	1.04	0.00	0.63	1.04	0.00	0.00	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	3.50	2.83	1.48	1.21	0.00	0.40	1.62	0.54	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	5.11	2.72	1.02	0.68	0.00	0.17	2.72	0.17	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	3.47	4.05	0.77	0.58	0.00	0.19	1.74	0.39	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	1.55	2.41	0.52	0.69	0.00	0.86	2.58	0.52	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	2.88	3.29	0.69	0.14	0.00	0.00	1.51	0.14	0.14	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	3.28	3.94	0.00	0.49	0.00	0.33	2.30	0.49	0.49	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	1.36	2.90	0.68	0.34	0.00	0.17	1.19	0.68	0.00	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	2.52	3.99	0.44	1.04	0.00	1.04	2.66	0.59	0.44	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	2.40	5.60	0.00	1.87	0.00	0.00	1.07	0.53	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	1.80	1.80	1.11	2.49	0.00	0.41	1.24	0.28	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	1.43	1.19	0.00	1.67	0.00	0.95	1.19	0.71	0.48	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	3.22	4.43	0.20	2.22	0.00	0.81	4.03	0.00	0.20	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	0.75	1.98	0.09	0.75	0.00	0.09	1.04	0.47	0.09	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	1.40	3.84	0.00	1.40	0.00	1.05	3.14	0.00	0.35	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	1.21	3.63	0.00	1.21	0.00	0.60	2.12	0.30	0.91	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	0.37	2.57	0.24	1.10	0.00	0.49	1.10	0.37	0.12	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	2.18	7.13	1.16	4.51	0.00	0.44	4.22	0.58	0.29	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	0.00	1.22	0.61	1.83	0.00	0.00	0.61	1.22	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	0.90	1.81	0.00	2.11	0.00	0.30	1.81	0.60	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	1.81	4.98	0.45	2.26	0.00	0.90	1.13	0.45	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	1.50	4.49	0.30	2.40	0.00	0.90	0.90	0.00	0.30	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	0.71	2.36	0.12	1.89	0.00	0.35	0.71	0.35	0.12	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	1.07	3.20	0.43	2.56	0.00	0.43	0.64	0.21	0.43	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	1.20	3.00	0.00	3.61	0.00	0.00	1.80	0.00	0.00	1.80
Schwann Cells, donor1	11498-119F4	15.61	2.44	4.14	2.07	0.19	1.13	0.75	1.13	1.32	0.94
Schwann Cells, donor2	11578-120F3	47.63	3.40	0.00	6.80	0.00	0.00	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	16.65	5.04	7.67	0.88	0.88	2.85	1.10	3.72	4.60	0.44
Sebocyte, donor1	11220-116B5	37.25	2.19	1.64	1.10	0.00	1.10	0.00	1.64	0.55	1.64
Sebocyte, donor2	11301-117B5	11.03	0.00	1.38	1.38	0.00	0.92	0.46	0.46	0.46	0.00
Sebocyte, donor3	11378-118B1	8.86	1.24	1.03	1.44	0.00	1.44	0.41	0.21	0.82	0.41
Sertoli Cells, donor1	11255-116F4	34.79	4.97	3.31	0.00	0.00	18.22	1.66	1.66	4.97	1.66
Sertoli Cells, donor2	11333-117F1	31.07	5.65	2.82	0.00	0.00	22.59	5.65	14.12	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	46.89	6.77	2.82	1.14	0.26	7.74	2.90	5.81	6.33	0.35
Skeletal Muscle Cells, donor2	11358-117H8	8.67	0.00	2.17	0.72	0.00	0.72	1.45	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	21.74	1.67	0.84	1.67	0.00	1.67	0.84	2.51	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	12.25	4.56	0.31	0.16	0.16	2.36	3.93	2.83	0.94	0.31
Skeletal Muscle Cells, donor5	11455-119A6	13.82	6.09	0.30	0.59	0.15	2.68	2.68	2.68	1.34	0.15
Skeletal Muscle Cells, donor6	11459-119B1	24.78	5.69	0.46	0.46	0.15	3.85	2.46	3.08	1.08	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	11.59	17.26	1.13	1.13	0.13	1.89	9.07	1.26	1.39	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	12.41	8.85	0.14	0.86	0.14	2.14	4.85	1.43	1.00	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	22.22	7.24	0.69	0.89	0.40	1.88	3.67	2.08	1.69	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	37.74	4.38	9.01	0.67	0.42	7.50	1.69	4.47	5.14	0.76
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	26.06	0.72	1.45	1.45	0.00	1.45	0.72	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	16.92	1.38	6.88	0.55	0.55	2.20	0.83	2.34	1.10	0.00
Skin - palm, donor1	10286-104F7	37.61	10.74	2.69	16.12	0.00	8.06	8.06	0.00	2.69	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	6.34	1.59	0.86	0.29	0.14	0.00	0.29	0.43	0.58	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	29.44	8.18	15.54	12.27	0.00	1.64	3.27	0.00	0.00	6.54
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	9.09	2.73	0.52	1.43	0.13	0.26	0.78	0.13	0.65	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	9.17	2.09	0.70	1.95	0.28	0.97	0.28	0.83	1.25	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	16.74	1.27	2.25	2.95	0.14	1.55	1.13	1.69	1.13	1.13
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	35.10	12.90	18.82	19.66	3.17	4.02	4.65	1.27	1.06	10.78
Small Airway Epithelial Cells, donor3	11406-118E2	23.23	1.80	1.57	5.70	0.37	1.35	0.90	3.45	1.57	2.92
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	26.54	0.31	2.16	0.00	0.93	2.78	0.31	1.54	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	22.46	2.00	7.78	0.67	2.00	1.33	1.11	3.11	0.89	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	29.98	4.11	1.76	0.00	1.18	0.59	0.00	2.94	4.11	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	35.58	5.08	0.22	0.88	0.22	1.55	2.21	1.10	1.10	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	10.63	2.76	1.18	0.39	0.39	1.18	0.79	1.97	1.18	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	27.81	0.77	2.32	0.00	0.00	1.55	1.55	1.55	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	15.01	21.02	1.00	2.00	1.00	8.01	7.01	2.00	3.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	16.37	2.79	2.66	0.00	0.27	1.86	0.93	2.66	1.20	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	42.56	6.65	1.11	0.00	0.22	11.97	3.55	6.21	3.99	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	16.26	2.69	5.76	1.54	1.28	1.92	0.51	1.15	0.64	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	13.02	9.44	2.60	0.65	1.95	1.95	1.63	1.95	0.65	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	23.63	18.61	5.32	0.59	1.18	0.89	4.43	2.95	2.66	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	11.67	11.67	1.71	0.71	1.00	0.85	3.13	1.85	0.71	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	19.68	3.25	0.33	0.00	0.00	0.98	0.49	0.49	0.49	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	64.54	23.44	0.61	0.61	0.00	4.26	11.26	0.00	1.52	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	44.96	5.81	0.76	0.00	0.76	1.01	2.53	0.25	1.01	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	0.00	0.00	12.24	0.00	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	22.41	1.91	1.91	0.48	0.95	1.91	0.48	2.38	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	8.55	11.65	0.29	0.29	0.15	2.06	3.24	0.44	1.62	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	9.26	5.81	1.08	0.22	0.00	2.15	3.66	0.43	1.08	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	9.66	8.08	0.21	0.63	0.00	1.15	1.89	1.36	0.52	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	15.62	3.87	1.55	0.15	0.15	1.24	0.77	2.32	1.39	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	5.39	3.23	1.08	0.00	1.08	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	19.43	2.39	3.29	0.00	0.00	1.20	1.20	2.99	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	9.22	10.24	1.02	0.00	0.68	1.02	2.05	1.37	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	18.14	32.67	1.81	1.18	0.16	5.65	5.73	3.14	3.61	0.71
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	32.10	4.33	0.10	0.20	0.60	5.33	1.51	2.21	1.41	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	41.19	5.92	2.50	0.00	0.68	10.47	2.50	8.42	5.01	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.85	2.42	0.60	0.60	1.21	0.60	1.81	1.81	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	13.78	11.13	0.00	0.53	0.00	2.38	3.71	2.12	1.85	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	16.25	6.52	4.39	0.80	0.13	3.86	1.73	3.60	1.07	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	11.90	11.14	0.50	0.38	1.00	4.13	4.63	2.38	1.88	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	19.02	6.34	1.27	0.25	0.00	2.28	3.80	0.76	1.52	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	47.34	7.54	2.71	0.30	0.90	2.71	2.41	2.86	1.96	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	28.51	1.50	0.00	0.00	0.00	0.75	0.75	0.00	6.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	112.42	2.58	10.34	6.46	0.00	0.00	3.88	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	18.14	5.12	3.72	0.93	0.47	1.40	2.79	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	30.29	5.05	2.02	0.50	3.03	5.55	1.51	3.53	4.54	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	26.64	2.19	1.57	0.31	0.00	4.39	1.25	2.82	2.19	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	7.37	2.06	0.29	0.00	0.29	0.59	0.88	1.47	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	51.82	11.66	0.25	0.17	0.33	5.25	3.25	4.42	2.92	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	29.43	14.95	0.93	0.47	0.47	7.47	2.80	1.40	4.20	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	13.96	4.03	2.45	0.00	1.87	1.30	1.58	1.73	0.58	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	26.01	4.84	4.08	0.00	1.02	0.51	1.78	2.80	1.27	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	20.87	2.26	5.64	0.56	0.56	1.32	1.13	0.94	0.75	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	12.02	12.44	0.28	0.98	0.14	2.66	3.07	3.21	2.10	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	9.38	9.55	0.59	0.25	0.42	2.01	2.93	3.27	1.68	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.81	2.38	0.00	0.00	0.00	0.00	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	10.28	3.91	1.96	0.24	1.22	0.24	0.73	1.47	1.47	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	17.68	8.18	1.55	0.00	0.00	6.19	3.76	5.08	1.10	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	16.68	12.29	0.88	0.00	0.00	3.51	4.10	2.05	1.17	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	19.82	6.22	0.00	0.58	0.00	0.19	3.30	0.97	1.75	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	28.30	4.50	1.06	0.26	0.53	2.64	2.64	0.79	1.06	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	4.46	9.30	0.00	0.00	0.00	1.49	4.46	2.60	1.49	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	29.47	11.50	0.00	0.36	0.00	2.16	4.67	1.44	2.52	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	26.12	9.37	1.14	0.28	1.14	2.84	3.41	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	50.81	13.00	2.36	0.79	0.39	3.54	3.54	1.97	3.15	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	30.22	10.41	0.76	0.25	0.25	2.79	4.57	2.03	3.05	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	43.13	11.58	0.00	0.40	0.40	2.40	2.00	3.99	3.99	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	28.01	6.27	0.42	0.00	0.00	4.60	3.76	3.76	1.67	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	38.96	9.17	5.50	0.00	2.29	7.33	3.67	2.75	2.29	0.00
Synoviocyte, donor1	11291-117A4	54.03	7.91	2.19	0.67	0.67	12.62	1.51	3.53	3.87	0.00
Synoviocyte, donor2	11368-117I9	26.82	5.03	3.18	1.34	0.67	4.86	2.51	5.87	5.53	0.50
Synoviocyte, donor3	11440-118H9	43.56	7.82	1.56	0.89	0.45	13.40	4.47	6.93	3.57	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	29.30	13.22	1.43	0.00	0.36	1.07	3.22	0.36	0.71	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	13.87	3.96	1.98	0.00	0.00	0.00	1.98	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	32.88	20.84	3.01	0.69	1.16	2.55	2.55	0.46	1.16	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	8.39	0.72	0.43	1.43	0.07	3.01	0.29	2.87	2.37	0.79
Tracheal Epithelial Cells, donor2	11369-118A1	4.25	0.00	0.39	0.39	0.77	0.77	0.77	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	6.30	0.00	0.00	1.15	0.00	0.00	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	14.15	53.76	0.98	18.08	1.60	4.43	8.98	5.17	3.69	6.27
Urethra, donor2	10319-105A4	82.73	26.98	3.60	26.98	0.00	8.99	8.99	0.00	0.00	7.19
Urothelial Cells, donor1	11520-119H8	5.31	0.53	1.06	1.33	0.27	0.53	0.00	0.80	0.27	0.53
Urothelial Cells, donor2	11600-120H7	8.01	0.00	0.40	0.80	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	8.02	0.00	0.69	1.15	0.23	0.69	0.00	0.23	0.69	0.23
Urothelial cells, donor0	11216-116B1	18.50	0.22	2.45	1.56	0.00	4.68	0.45	2.23	1.78	1.56
Whole blood (ribopure), donor090309, donation1	12179-129A1	17.80	71.18	4.45	29.36	17.80	6.23	7.12	3.56	1.78	29.36
Whole blood (ribopure), donor090309, donation2	12180-129A2	12.87	48.61	5.72	27.16	17.16	10.01	7.15	4.29	2.86	38.60
Whole blood (ribopure), donor090309, donation3	12181-129A3	18.48	48.60	4.79	25.33	19.85	13.01	8.21	1.37	5.48	28.07
Whole blood (ribopure), donor090325, donation1	12176-128I7	23.07	79.20	3.10	7.58	30.30	13.77	8.26	6.54	6.54	9.64
Whole blood (ribopure), donor090325, donation2	12177-128I8	20.34	70.30	3.49	5.23	36.02	9.30	8.72	3.49	8.13	12.78
Whole blood (ribopure), donor090612, donation1	12182-129A4	12.49	46.86	3.12	23.95	22.91	11.45	3.12	7.29	3.12	23.95
Whole blood (ribopure), donor090612, donation2	12183-129A5	21.11	51.40	3.67	17.44	29.37	9.18	5.51	2.75	2.75	17.44
Whole blood (ribopure), donor090612, donation3	12184-129A6	14.61	31.95	3.65	14.61	12.78	15.52	6.39	2.74	1.83	24.65
Wilms' tumor cell line:G-401	10809-111A8	2.10	0.74	0.00	0.00	0.00	0.62	0.12	0.74	0.25	0.00
Wilms' tumor cell line:HFWT	10597-108E3	0.00	0.00	0.00	3.52	0.00	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	5.03	0.84	0.00	2.51	0.00	2.23	0.56	0.28	0.00	2.23
achilles tendon, donor2	10292-104G4	43.40	14.47	16.53	31.00	0.00	12.40	6.20	4.13	0.00	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	22.44	68.33	1.27	0.76	6.37	24.99	7.39	8.67	5.86	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	18.34	13.23	1.86	5.80	0.00	2.32	4.41	1.16	0.70	1.16
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.00	12.46	0.00	3.44	0.00	1.42	2.85	0.59	0.12	0.95
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	9.80	3.27	0.27	5.44	1.36	4.90	1.09	0.54	0.00	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	25.30	23.61	0.28	0.28	0.00	4.22	4.50	1.41	1.12	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	8.25	7.82	5.50	4.44	9.52	0.85	2.33	0.63	1.06	1.90
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	5.99	4.36	1.36	5.72	11.71	7.35	0.54	2.99	1.36	2.99
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	11.90	5.29	49.79	1.76	2.64	9.25	1.76	3.08	2.64	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	13.07	22.87	4.08	3.27	2.45	5.72	5.72	3.27	3.68	2.45
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	8.15	1.55	26.40	2.72	0.00	6.99	0.78	6.21	1.94	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	7.36	1.10	1.66	4.60	0.00	3.68	0.55	0.92	1.47	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	3.90	11.70	19.50	39.01	0.00	3.90	3.90	0.00	0.00	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	20.22	14.64	6.51	1.39	9.99	7.20	1.86	3.25	1.63	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	0.78	0.00	6.21	3.37	0.00	0.52	0.26	1.04	0.78	2.07
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	0.00	0.29	8.77	4.38	0.00	1.75	0.00	0.88	1.17	3.21
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	18.13	0.00	13.01	4.18	0.46	1.86	0.00	1.39	1.39	4.65
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	9.87	0.82	12.34	6.58	0.00	4.11	0.41	2.06	1.23	3.70
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	17.50	0.00	13.20	2.46	0.00	1.84	0.00	2.15	1.23	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	14.93	0.00	32.86	3.41	0.00	5.55	0.00	2.99	2.13	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	13.04	0.00	22.14	2.12	0.00	4.85	0.00	2.73	0.91	2.12
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	14.20	0.00	25.76	3.13	0.00	3.37	0.00	1.44	1.44	2.17
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	2.23	0.00	4.01	2.45	0.00	2.00	0.00	0.67	0.45	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	10.67	16.34	0.33	2.67	0.00	2.00	4.00	2.00	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	29.73	26.01	3.72	1.86	1.86	3.72	7.43	1.86	1.86	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	11.30	10.17	1.51	0.38	4.14	5.65	3.77	1.88	1.88	2.26
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	46.67	17.45	0.00	6.54	0.44	4.80	6.54	1.31	1.74	2.62
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	20.62	13.12	0.00	7.50	7.50	7.50	7.50	13.12	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	20.25	0.94	0.71	19.31	0.00	3.30	2.35	0.00	0.00	4.24
adipose tissue, adult, pool1	10010-101C1	44.83	38.16	2.79	7.14	0.00	4.03	14.27	1.71	1.86	2.64
adipose, donor1	10184-103D4	0.59	0.00	2.35	14.07	4.10	1.76	0.00	7.04	1.76	8.21
adipose, donor2	10185-103D5	7.30	0.00	6.49	12.98	0.41	2.03	0.00	1.22	0.81	3.65
adipose, donor3	10186-103D6	7.62	0.27	9.53	11.71	4.08	3.81	0.00	1.63	1.91	3.54
adipose, donor4	10187-103D7	16.47	0.00	12.13	7.80	17.34	0.87	1.73	1.73	0.87	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	1.26	0.00	0.32	8.05	0.00	0.47	0.00	0.47	0.16	1.58
adrenal gland, adult, pool1	10081-102A9	3.64	3.64	0.00	3.64	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	5.00	0.00	0.00	0.71	0.00	1.79	0.00	1.07	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	11.59	0.23	12.75	2.55	0.23	3.48	0.00	6.03	2.78	1.39
amniotic membrane cells, donor2	12236-129G4	5.07	0.68	8.79	1.69	1.01	3.38	0.34	2.37	1.01	1.35
amniotic membrane cells, donor3	12237-129G5	7.37	0.00	15.91	3.54	0.00	5.89	0.00	5.30	1.77	0.88
amygdala - adult, donor10196	10167-103B5	14.23	3.56	0.00	3.56	1.19	1.19	0.00	4.74	1.19	1.19
amygdala, adult, donor10252	10151-102I7	19.47	8.31	1.42	10.34	0.41	4.06	3.04	2.64	1.82	4.06
amygdala, newborn, donor10223	10360-105E9	10.65	6.13	4.52	4.52	1.29	3.23	3.87	0.97	2.26	2.26
anaplastic carcinoma cell line:8305C	10428-106D5	15.92	7.51	2.16	4.07	0.00	5.48	1.66	1.66	2.16	1.27
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	8.38	0.00	0.00	0.00	0.00	1.10	0.00	0.88	0.44	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	1.00	0.33	0.00	0.67	0.33	0.67	0.00	0.33	0.33	0.67
aorta, adult, pool1	10052-101G7	85.12	25.30	9.02	12.16	2.35	10.40	7.85	18.83	5.69	6.47
appendix, adult	10189-103D9	48.51	72.97	8.15	15.14	24.84	7.76	15.14	3.10	4.66	5.43
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	12.04	34.74	0.34	6.19	0.00	10.32	13.76	5.16	3.44	1.03
artery, adult	10190-103E1	28.53	5.43	1.36	8.15	0.00	9.51	2.72	2.72	4.08	1.36
astrocytoma cell line:TM-31	10425-106D2	14.78	10.14	6.37	6.08	5.22	4.20	3.33	2.17	1.59	1.74
b cell line:RPMI1788	10427-106D4	0.00	0.15	0.00	0.15	0.00	0.00	0.00	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	17.76	1.39	2.50	1.11	0.00	3.61	0.83	2.50	0.83	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	14.19	5.26	1.09	2.48	0.69	2.48	1.79	1.69	0.89	0.99
bile duct carcinoma cell line:TFK-1	10496-107C1	4.85	0.00	2.51	12.05	0.00	5.86	0.00	4.85	1.84	5.02
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	2.24	0.56	3.91	8.95	0.00	5.59	0.00	2.24	0.56	10.07
bladder, adult, pool1	10011-101C2	48.56	38.78	9.89	4.78	4.35	7.17	12.39	4.78	4.78	1.74
blood, adult, pool1	10053-101G8	26.58	26.58	6.64	6.64	15.50	8.86	2.21	22.15	13.29	6.64
bone marrow stromal cell line:StromaNKtert	10686-109F2	18.84	18.84	5.14	0.86	0.00	1.71	4.28	0.86	1.71	1.71
bone marrow, adult	10192-103E3	14.17	31.04	2.70	3.37	0.67	7.42	9.45	2.70	2.02	1.35
brain, adult, donor1	10084-102B3	30.75	3.08	2.05	3.08	0.00	6.15	3.08	6.15	0.00	1.03
brain, adult, pool1	10012-101C3	21.49	6.35	2.56	1.89	0.22	4.01	1.67	3.23	3.12	1.22
brain, fetal, pool1	10085-102B4	85.48	2.67	13.36	2.67	0.00	13.36	0.00	13.36	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	25.44	0.33	4.29	14.21	0.00	8.59	0.00	3.96	1.65	5.62
breast carcinoma cell line:MDA-MB-453	10419-106C5	4.12	0.00	15.23	38.82	0.00	2.50	0.12	2.62	1.87	27.46
breast, adult, donor1	10080-102A8	44.83	18.31	3.16	7.58	1.26	2.53	6.94	1.26	0.00	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	14.48	3.94	3.81	3.81	0.89	4.70	1.40	4.70	1.78	1.14
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	5.57	25.36	1.55	5.88	0.00	6.49	7.73	6.18	2.47	2.47
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	2.99	0.23	0.00	0.23	0.00	1.38	0.23	0.69	0.46	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	1.21	0.73	1.94	2.91	0.00	2.91	0.48	1.45	0.48	0.48
carcinoid cell line:NCI-H1770	10703-109H1	5.17	0.00	0.47	3.76	0.00	4.23	0.00	2.35	1.41	0.00
carcinoid cell line:NCI-H727	10735-110B6	64.32	34.24	0.88	9.30	0.00	2.41	8.53	2.30	1.42	4.70
carcinoid cell line:SK-PN-DW	10719-109I8	21.87	8.56	0.00	5.70	0.00	6.65	3.17	6.34	1.58	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	14.37	0.00	2.40	3.46	0.27	2.13	0.53	2.13	1.33	0.80
caudate nucleus - adult, donor10196	10177-103C6	71.38	6.91	10.36	4.61	0.00	4.61	2.30	4.61	6.91	1.15
caudate nucleus, adult, donor10252	10164-103B2	75.97	12.88	19.74	8.70	0.50	10.21	4.35	8.20	5.69	3.35
caudate nucleus, adult, donor10258	10379-105H1	95.52	3.82	17.58	3.06	0.76	4.58	1.53	4.58	6.11	3.06
caudate nucleus, newborn, donor10223	10354-105E3	118.29	10.25	19.04	5.13	4.39	3.30	5.86	2.20	5.49	2.20
cerebellum - adult, donor10196	10173-103C2	2.91	0.00	0.00	2.91	0.00	0.00	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	4.70	7.26	2.56	33.31	0.64	3.20	2.56	1.71	2.14	10.46
cerebellum, adult, pool1	10083-102B2	4.14	1.38	1.03	4.83	0.00	2.07	0.34	1.72	0.00	1.38
cerebellum, newborn, donor10223	10357-105E6	2.49	24.08	2.49	26.57	0.83	1.66	14.11	1.66	1.66	9.13
cerebral meninges, adult	10188-103D8	20.42	7.31	4.29	5.04	0.25	4.29	4.03	3.78	4.03	1.51
cerebrospinal fluid, donor2	10294-104G6	18.27	4.39	2.92	6.58	5.12	2.19	0.73	3.65	0.73	2.19
cervical cancer cell line:D98-AH2	10552-107I3	1.01	0.00	0.72	4.17	0.00	0.58	0.00	0.29	0.00	1.29
cervical cancer cell line:ME-180	10553-107I4	14.91	1.82	2.15	5.30	0.00	5.14	0.66	2.32	2.49	1.49
cervix, adult, pool1	10013-101C4	41.68	26.46	5.98	9.76	0.52	5.77	13.44	5.35	4.30	5.04
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	27.73	0.70	20.48	1.11	0.00	8.36	0.70	3.48	4.32	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	31.35	18.29	0.00	5.23	0.00	1.31	3.92	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	1.24	0.12	0.00	11.31	0.00	0.99	0.37	0.87	0.62	1.99
choriocarcinoma cell line:SCH	10785-110H2	0.25	0.00	0.12	8.75	0.00	1.11	0.00	1.97	0.37	2.09
choriocarcinoma cell line:T3M-3	10618-108G6	0.00	0.00	0.00	7.12	0.00	0.95	0.00	1.42	0.00	0.47
chorionic membrane cells, donor1	12238-129G6	5.98	1.71	7.12	3.13	0.00	0.85	1.14	1.42	1.71	1.14
chorionic membrane cells, donor2	12239-129G7	7.95	3.78	3.48	1.49	0.00	1.59	0.99	1.89	0.70	0.60
chorionic membrane cells, donor3	12240-129G8	6.04	3.85	3.30	7.69	0.55	4.95	1.10	1.65	1.65	3.30
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	3.03	3.03	0.00	4.04	12.12	7.07	1.01	1.01	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	6.15	13.06	8.64	2.88	2.31	2.50	3.65	3.65	1.92	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	7.60	14.99	1.69	8.45	2.75	3.17	6.55	3.17	1.06	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	4.88	8.47	0.26	3.34	0.26	1.03	1.54	0.51	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	4.60	7.98	0.48	1.94	0.00	1.45	2.90	0.48	0.00	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	3.46	12.83	0.00	2.44	0.00	1.63	3.87	0.20	0.81	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	1.47	6.18	0.00	2.06	0.00	1.18	0.88	0.88	0.59	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	19.81	30.49	1.56	8.08	5.21	2.61	11.99	3.39	1.04	4.95
clear cell carcinoma cell line:JHOC-5	10638-108I8	0.69	0.00	0.46	1.14	0.00	0.69	0.00	0.00	0.46	0.46
clear cell carcinoma cell line:TEN	10636-108I6	2.95	9.37	1.04	3.99	0.00	3.30	5.55	2.43	1.39	1.21
colon carcinoma cell line:CACO-2	10513-107D9	39.35	29.10	4.94	0.18	19.40	7.14	5.13	6.96	3.66	0.55
colon carcinoma cell line:COLO-320	10420-106C6	6.08	0.00	8.36	31.55	0.00	3.80	1.14	2.28	1.52	10.64
colon, adult, donor1	10082-102B1	66.64	30.94	9.52	17.85	3.57	7.14	14.28	14.28	5.95	9.52
colon, adult, pool1	10014-101C5	28.44	41.60	7.87	15.28	2.00	6.35	17.98	8.46	5.52	7.29
colon, fetal, donor1	10070-101I7	35.84	55.00	3.09	16.07	13.60	18.54	22.87	17.92	1.24	3.71
common myeloid progenitor CMP, donor1	12130-128D6	9.17	4.58	110.00	123.76	13.75	0.00	9.17	0.00	4.58	32.08
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00	0.00	0.00	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	53.54	17.42	5.52	12.32	0.00	17.42	0.85	5.52	4.25	4.67
cord blood derived cell line:COBL-a 24h infection	10453-106G3	22.19	6.49	1.21	7.09	0.00	5.13	0.45	2.72	2.87	3.17
cord blood derived cell line:COBL-a untreated	10449-106F8	20.02	9.02	1.27	10.43	0.00	9.73	0.56	2.12	1.83	2.26
corpus callosum, adult, pool1	10042-101F6	34.16	8.18	3.32	9.73	1.44	1.99	2.21	1.77	1.33	4.09
cruciate ligament, donor2	10295-104G7	72.94	32.42	10.54	24.31	5.67	11.35	16.21	3.24	0.00	9.73
diaphragm, fetal, donor1	10069-101I6	42.54	12.04	4.01	20.06	3.21	4.01	3.21	3.21	3.21	0.00
diencephalon, adult	10193-103E4	29.76	2.64	3.60	1.68	0.72	6.00	0.72	4.56	2.40	1.68
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	5.28	20.21	8.95	1.38	0.00	11.25	2.98	6.89	3.90	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	18.21	3.85	1.54	11.03	0.00	3.59	0.51	1.80	1.80	3.59
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	0.00	0.00	0.00	3.13	0.00	1.20	0.00	0.48	0.48	0.96
ductus deferens, adult	10196-103E7	12.96	8.47	2.99	16.45	0.00	3.49	5.98	0.50	1.50	6.98
duodenum, fetal, donor1, tech_rep1	10071-101I8	43.21	43.21	1.44	21.60	23.04	11.52	5.76	17.28	2.88	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	36.78	38.99	3.68	12.51	27.22	11.77	4.41	4.41	2.21	10.30
dura mater, adult, donor1	10041-101F5	92.66	23.54	119.92	7.52	4.54	6.85	8.51	5.37	5.12	5.12
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	6.22	2.66	3.78	6.66	0.67	1.78	0.22	0.89	0.67	2.66
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	9.74	4.01	4.59	2.29	1.43	3.44	0.57	1.15	1.72	1.72
embryonic pancreas cell line:1B2C6	10604-108F1	17.88	2.47	0.00	4.93	0.00	3.08	1.85	1.23	0.00	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	5.75	1.51	0.00	1.51	0.00	1.21	0.30	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	14.20	2.47	0.31	6.17	0.00	0.31	2.47	1.23	0.00	1.85
embryonic pancreas cell line:2C6	10603-108E9	10.51	1.31	0.00	3.94	0.00	2.63	0.00	6.57	0.00	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	1.01	2.68	0.00	0.67	0.00	0.00	0.67	0.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	0.00	0.36	0.00	3.26	0.36	1.99	0.18	0.36	0.00	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	2.09	0.00	0.16	2.57	0.16	0.80	0.00	0.32	0.00	0.96
epidermoid carcinoma cell line:A431	10426-106D3	7.00	0.11	0.33	1.89	0.00	1.22	0.22	0.56	1.00	1.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	11.11	0.00	5.06	2.64	0.00	1.76	0.00	0.88	0.44	1.76
epididymis, adult	10197-103E8	20.93	8.37	4.19	9.42	0.21	5.44	6.49	2.51	2.72	3.14
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	20.58	9.76	11.00	4.97	0.00	8.52	3.90	4.61	1.60	3.02
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	2.88	5.11	0.13	1.57	0.00	1.05	2.62	1.18	0.79	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	3.15	5.02	0.10	2.46	0.00	1.48	2.56	1.18	0.98	0.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	4.15	3.14	0.34	0.67	0.00	1.01	2.46	1.34	0.67	0.00
esophagus, adult, pool1	10015-101C6	37.37	21.24	5.63	6.05	1.59	6.90	6.26	5.31	4.88	2.12
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	0.25	0.00	0.63	2.50	0.00	0.13	0.00	0.00	0.13	0.25
eye - muscle inferior rectus, donor1	10272-104E2	36.22	31.39	12.07	33.80	2.41	16.90	12.07	2.41	2.41	4.83
eye - muscle lateral, donor2	10298-104H1	18.94	8.42	6.31	14.73	0.00	8.42	4.21	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	35.72	4.46	4.46	22.32	0.00	5.95	4.46	2.98	0.00	2.98
eye - muscle superior, donor2	10297-104G9	51.59	8.03	13.76	10.32	1.15	11.46	10.32	3.44	0.00	2.29
eye - vitreous humor, donor1	10268-104D7	13.12	2.91	0.00	16.03	2.91	2.91	0.00	1.46	1.46	1.46
eye, fetal, donor1	10054-101G9	34.83	9.66	6.61	11.44	1.53	3.81	3.31	10.42	5.08	2.80
fibrosarcoma cell line:HT-1080	10758-110E2	26.80	6.28	3.21	1.28	0.00	4.49	1.28	5.00	2.05	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	64.82	10.92	3.80	1.90	0.71	7.60	3.56	6.89	3.32	1.90
frontal lobe, adult, pool1	10040-101F4	39.50	8.54	6.29	4.32	1.03	3.57	2.63	3.57	3.57	2.63
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	1.50	1.20	0.60	2.40	0.00	1.50	0.30	0.90	0.00	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	11.98	7.13	4.21	1.74	0.00	2.29	3.93	1.55	1.01	0.82
gall bladder, adult	10198-103E9	33.08	25.11	4.35	9.17	3.14	8.45	10.86	2.66	0.97	4.59
gamma delta positive T cells, donor1	11937-126A2	15.57	100.39	0.00	0.54	2.68	6.44	8.59	2.68	2.15	0.54
gamma delta positive T cells, donor2	11938-126A3	12.70	103.46	0.37	2.24	4.11	10.46	13.07	3.36	4.86	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	6.76	2.32	2.75	1.06	0.00	2.32	1.90	1.48	0.21	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	29.21	8.32	6.38	6.77	0.00	3.48	2.90	4.06	2.71	4.06
gastric cancer cell line:AZ521	10549-107H9	1.64	0.00	2.13	5.25	0.00	0.49	0.00	1.64	1.15	2.62
gastric cancer cell line:GSS	10560-108A2	22.88	0.00	0.00	0.92	0.00	1.83	0.00	0.00	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	125.42	50.49	34.27	13.48	2.97	17.82	14.16	14.62	7.31	8.22
giant cell carcinoma cell line:LU65	10487-107B1	6.08	0.34	0.00	4.36	0.00	2.98	0.46	2.07	0.69	0.92
giant cell carcinoma cell line:Lu99B	10433-106E1	16.10	12.74	1.40	4.48	0.00	4.76	6.30	2.38	1.12	1.26
glassy cell carcinoma cell line:HOKUG	10688-109F4	9.48	0.75	1.50	5.74	0.00	2.24	0.50	1.75	0.50	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	13.41	2.64	3.91	0.84	0.00	2.64	1.48	1.48	0.53	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	11.80	1.40	2.81	0.98	0.00	2.39	1.83	1.12	0.84	0.14
glioblastoma cell line:T98G	10485-107A8	24.94	42.38	4.19	0.66	0.00	7.06	6.29	4.86	3.09	0.11
glioma cell line:GI-1	10413-106B8	8.49	6.44	12.59	0.59	0.00	2.93	3.22	2.05	1.46	0.59
globus pallidus - adult, donor10196	10175-103C4	43.73	1.46	4.37	2.19	1.46	2.92	1.46	3.64	2.92	2.92
globus pallidus, adult, donor10252	10161-103A8	28.07	6.83	8.30	23.19	0.49	9.52	0.49	5.61	3.66	8.30
globus pallidus, adult, donor10258	10367-105F7	13.69	4.11	0.00	6.85	1.37	8.22	0.00	6.85	2.74	4.11
globus pallidus, newborn, donor10223	10364-105F4	52.23	5.86	8.53	5.33	1.60	3.20	1.60	1.07	1.07	2.13
granulocyte macrophage progenitor, donor1	12131-128D7	19.58	0.00	127.25	51.39	22.02	0.00	2.45	0.00	0.00	19.58
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	43.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	0.00	15.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	32.00	7.68	4.16	1.60	0.96	5.44	4.48	1.92	0.96	1.60
hIPS +CCl2, biol_rep1	14383-156B9	5.97	0.00	2.75	2.75	10.56	1.38	0.00	2.30	0.92	1.38
hIPS +CCl2, biol_rep2	14384-156C1	3.66	0.46	3.66	2.29	11.43	0.91	0.00	0.00	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	3.22	0.64	3.22	1.29	7.09	1.29	0.00	0.00	0.64	0.00
hIPS, biol_rep1	14380-156B6	5.75	0.00	1.44	4.31	15.81	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	2.06	0.69	0.69	1.37	5.49	0.69	0.00	0.00	0.69	0.69
hIPS, biol_rep3	14382-156B8	29.79	2.21	1.10	1.10	5.52	4.41	1.10	0.00	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	4.88	8.05	0.00	0.00	0.29	3.16	4.31	0.29	0.86	0.00
heart - mitral valve, adult	10205-103F7	56.80	29.60	10.46	13.15	1.20	6.88	14.05	2.69	2.69	2.39
heart - pulmonic valve, adult	10206-103F8	46.80	16.73	3.40	11.24	1.05	8.11	7.58	2.35	1.83	3.40
heart - tricuspid valve, adult	10207-103F9	124.90	45.80	5.83	18.32	2.50	14.15	18.32	6.66	1.67	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	10.00	1.63	2.04	3.47	0.82	1.84	1.02	2.24	0.61	2.65
heart, adult, diseased, donor1	10051-101G6	12.77	3.41	2.98	5.96	0.43	1.70	2.98	1.28	0.85	1.70
heart, adult, pool1	10016-101C7	14.95	8.74	0.69	5.29	0.46	3.45	6.67	2.99	3.22	1.15
heart, fetal, pool1	10046-101G1	49.90	37.58	12.22	18.28	6.88	4.00	20.64	4.83	4.21	6.47
hepatic mesenchymal tumor cell line:LI90	10778-110G4	60.47	15.43	11.11	0.93	0.31	9.26	4.32	6.48	1.85	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	55.89	0.00	16.65	14.27	10.70	8.32	0.00	9.51	1.19	4.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	30.05	0.11	15.14	4.09	8.73	4.53	0.00	6.19	4.97	2.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	27.55	0.24	18.69	4.61	5.46	3.28	0.00	5.70	3.28	1.58
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	33.04	0.10	21.52	5.05	7.07	4.75	0.20	5.36	3.54	2.63
hepatoma cell line:Li-7	10484-107A7	5.34	19.02	4.56	3.34	0.22	4.34	3.23	2.56	1.22	3.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.00	11.56	0.00	1.41	5.63	1.31	2.61	1.11	0.40	0.50
hippocampus - adult, donor10196	10169-103B7	27.44	2.84	1.89	0.95	0.00	6.62	0.95	3.79	1.89	2.84
hippocampus, adult, donor10252	10153-102I9	17.55	7.55	2.65	11.43	1.02	10.41	5.31	4.49	4.08	4.08
hippocampus, adult, donor10258	10374-105G5	33.36	2.99	4.48	1.00	0.00	0.50	2.49	0.00	1.00	0.50
hippocampus, newborn, donor10223	10363-105F3	10.57	3.52	0.70	2.11	0.35	1.41	1.76	2.11	0.70	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	1.22	0.00	0.61	4.88	37.23	3.05	0.61	1.22	1.22	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	1.77	0.20	0.98	4.12	20.42	1.57	0.39	0.79	1.18	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	2.29	0.25	0.51	4.57	26.41	0.76	0.00	0.25	1.27	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	0.00	0.00	0.56	8.46	3.95	2.26	0.00	0.00	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	0.26	0.00	1.03	10.07	2.84	1.81	0.00	0.26	1.55	3.10
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	1.52	0.00	0.76	7.21	3.42	3.04	0.38	0.00	0.38	2.66
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	8.17	0.00	7.59	20.73	6.13	1.75	0.00	0.29	2.34	5.26
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	4.09	0.00	7.97	14.65	8.62	3.23	0.00	0.43	1.08	4.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	5.84	0.83	4.59	10.84	6.67	2.09	0.00	1.25	1.25	3.75
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	6.87	0.47	2.60	4.26	4.50	2.13	0.00	0.95	0.71	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	8.20	1.13	5.46	7.07	5.46	5.63	0.80	1.61	1.61	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	10.10	2.69	7.41	4.71	8.08	0.00	2.02	0.00	0.00	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	2.35	0.16	1.25	3.13	29.73	2.03	0.31	1.10	1.56	1.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	0.98	0.00	2.46	5.40	30.46	1.47	0.00	2.46	0.49	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	2.62	1.75	0.00	6.98	40.15	1.75	0.00	2.62	2.62	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	1.91	0.00	1.91	11.65	1.72	2.67	0.00	0.57	1.53	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	0.44	0.00	3.05	9.16	1.31	2.62	0.00	1.31	0.87	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	2.00	0.00	3.00	17.49	4.00	0.50	0.00	1.50	2.50	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	6.97	0.00	6.97	6.03	1.32	2.07	0.19	0.57	0.38	2.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	6.82	0.00	6.37	4.09	0.91	2.27	0.00	0.91	1.36	2.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	5.95	0.00	6.26	9.40	1.88	0.63	0.00	0.31	1.88	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	6.70	0.65	6.86	6.53	2.94	6.04	0.49	1.14	3.10	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	9.29	0.58	8.71	3.77	2.90	5.23	0.29	2.32	1.45	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	9.57	1.49	8.97	6.28	1.79	2.39	0.30	2.09	2.69	2.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	0.92	0.37	0.55	4.62	21.80	3.33	0.18	1.11	0.92	1.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	0.57	0.57	1.14	4.85	20.54	1.71	0.86	2.85	1.14	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	2.86	0.82	0.82	5.72	31.44	1.22	0.41	2.04	0.82	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	1.06	0.00	2.46	7.75	3.52	1.41	0.35	1.41	0.70	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	1.90	0.32	2.85	4.75	3.17	1.27	0.00	0.32	0.95	1.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	1.82	0.30	4.84	6.36	4.24	1.82	0.00	1.21	0.00	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	4.65	1.03	6.21	5.69	3.10	3.10	0.52	1.03	1.03	3.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	3.98	0.66	4.65	7.31	0.00	3.32	0.00	1.33	1.33	3.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	3.33	1.28	4.36	5.64	1.80	0.77	0.51	0.51	0.26	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	8.69	1.79	5.11	4.60	1.28	2.81	0.26	2.05	2.05	2.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	9.84	1.51	6.06	6.06	0.76	4.54	0.76	0.76	0.00	6.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	6.39	1.34	3.36	2.69	3.02	2.69	0.34	1.68	3.02	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	0.97	0.24	0.72	3.62	19.56	2.42	0.00	1.45	1.45	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	0.45	0.00	0.45	6.24	19.61	0.89	0.00	1.78	0.89	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	0.00	0.00	2.93	3.90	20.00	2.44	0.00	1.46	0.98	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	1.83	0.31	0.92	8.56	1.83	0.92	0.00	0.61	0.31	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	0.00	0.00	3.25	9.76	3.25	0.00	0.00	6.51	3.25	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	0.33	0.00	1.32	10.92	3.31	0.66	0.00	0.66	0.00	2.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	2.19	0.00	10.40	10.95	4.38	2.74	0.55	0.00	0.00	6.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	2.17	1.09	3.62	11.94	2.53	1.45	0.36	0.72	0.72	3.26
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	2.85	0.71	7.47	6.76	2.85	2.49	0.00	1.07	1.78	4.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	7.16	1.19	3.58	2.39	8.35	3.58	1.19	1.19	2.39	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	4.74	1.76	3.39	6.23	6.09	0.95	0.68	1.49	1.08	2.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	3.77	0.54	3.23	2.96	2.69	0.81	0.81	1.35	2.69	1.08
immature langerhans cells, donor1	11904-125F5	116.47	35.11	3.39	1.45	0.24	5.57	8.96	10.17	5.09	0.97
immature langerhans cells, donor2	11905-125F6	93.47	3.96	2.38	3.17	0.00	3.17	3.96	0.00	1.58	0.79
insula, adult, pool1	10039-101F3	38.89	9.27	6.91	3.31	0.85	3.31	2.74	2.18	1.51	2.37
keratoacanthoma cell line:HKA-1	10791-110H8	1.30	0.33	1.63	2.28	0.00	1.63	0.33	1.95	0.00	1.30
kidney, adult, pool1	10017-101C8	9.51	6.01	0.50	4.81	2.60	1.70	4.91	1.60	1.10	2.00
kidney, fetal, pool1	10045-101F9	9.69	18.60	1.63	14.50	5.23	0.71	8.21	1.20	0.71	5.02
large cell lung carcinoma cell line:IA-LM	10509-107D5	51.84	54.25	3.69	2.84	0.00	10.94	9.80	10.79	3.69	2.56
large cell lung carcinoma cell line:NCI-H460	10839-111E2	0.55	0.28	0.14	1.11	0.00	0.41	0.28	0.55	0.28	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	11.56	4.95	0.55	5.87	0.00	1.65	1.65	1.47	0.73	1.10
left atrium, adult, donor1	10079-102A7	29.97	15.80	1.63	4.90	1.63	1.63	14.17	3.81	1.63	2.72
left ventricle, adult, donor1	10078-102A6	12.14	5.56	0.51	2.02	0.00	0.51	6.07	2.02	1.52	2.53
leiomyoblastoma cell line:G-402	10721-110A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	2.87	0.36	0.00	0.00	0.00	1.80	1.08	0.72	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	2.17	1.09	0.54	0.00	0.00	0.54	1.09	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	8.98	1.94	0.73	0.73	0.00	0.97	1.46	1.21	0.73	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	6.35	0.00	0.00	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	13.59	17.77	1.05	2.09	2.09	2.09	3.14	3.14	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	8.50	1.65	3.07	5.67	0.71	1.89	1.30	1.65	0.83	1.89
liposarcoma cell line:KMLS-1	10782-110G8	21.24	7.03	22.03	1.25	0.00	3.75	4.69	4.06	0.94	1.09
liposarcoma cell line:SW 872	10726-110A6	18.03	14.74	0.00	2.31	0.24	1.58	4.02	2.31	0.85	0.73
liver, adult, pool1	10018-101C9	5.35	17.34	0.32	5.83	0.49	2.27	6.97	2.59	1.30	4.05
liver, fetal, pool1	10086-102B5	10.35	24.46	1.88	4.70	0.94	0.94	12.23	4.70	0.94	2.82
locus coeruleus - adult, donor10196	10182-103D2	15.02	2.19	2.19	5.54	0.29	4.08	1.75	1.46	0.58	2.33
locus coeruleus, adult, donor10252	10165-103B3	9.60	4.06	1.66	13.66	0.37	4.06	1.85	2.40	3.32	4.61
locus coeruleus, adult, donor10258	10375-105G6	7.90	2.54	0.56	3.95	0.56	0.85	1.41	0.85	1.13	1.41
locus coeruleus, newborn, donor10223	10362-105F2	5.89	12.62	1.68	5.05	1.68	2.94	3.79	1.26	1.26	0.00
lung adenocarcinoma cell line:A549	10499-107C4	0.83	7.75	0.55	5.95	0.00	2.63	4.15	1.94	0.42	1.94
lung adenocarcinoma cell line:PC-14	10408-106B3	0.69	7.58	0.00	2.76	0.00	0.69	4.14	0.00	0.69	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	14.24	17.80	8.70	5.80	0.13	1.85	4.88	2.37	1.71	2.11
lung, adult, pool1	10019-101D1	31.54	50.32	7.09	10.28	5.08	3.19	6.62	5.08	3.07	5.43
lung, fetal, donor1	10068-101I5	51.37	135.00	30.54	20.26	23.40	12.27	30.25	3.71	1.14	11.42
lung, right lower lobe, adult, donor1	10075-102A3	60.03	49.95	19.25	13.75	14.66	13.75	6.87	16.04	3.21	4.58
lymph node, adult, donor1	10077-102A5	31.72	56.33	2.84	1.42	30.30	5.68	12.31	8.52	1.89	0.00
lymphangiectasia cell line:DS-1	10727-110A7	6.14	18.41	0.00	0.22	0.00	2.85	2.85	3.29	1.32	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	5.58	66.11	1.51	0.15	46.03	10.26	7.40	6.64	4.98	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	9.34	6.80	0.85	4.25	0.00	1.70	0.85	1.70	0.00	4.25
mature adipocyte, donor1	12231-129F8	14.65	8.44	0.89	2.22	0.00	1.33	7.55	1.33	0.00	3.11
mature adipocyte, donor2	12232-129F9	18.05	13.07	0.00	4.77	0.00	0.83	9.34	1.25	0.21	1.04
mature adipocyte, donor3	12233-129G1	14.46	7.35	0.00	2.61	0.24	0.71	5.22	0.71	0.24	0.71
mature adipocyte, donor4	12234-129G2	8.16	5.00	0.53	5.26	0.00	0.26	5.53	2.11	0.00	3.16
maxillary sinus tumor cell line:HSQ-89	10414-106B9	49.08	14.77	3.57	15.01	1.67	4.53	5.48	5.48	3.57	7.39
medial frontal gyrus - adult, donor10196	10170-103B8	31.58	5.64	2.26	1.13	0.00	6.77	3.38	7.90	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	29.06	22.07	4.23	8.64	0.55	9.38	5.52	4.41	2.76	4.41
medial frontal gyrus, adult, donor10258	10368-105F8	19.06	4.77	1.59	0.95	0.00	2.54	1.59	3.49	1.91	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	17.49	24.74	2.56	3.84	3.84	1.71	5.54	5.54	5.97	2.56
medial temporal gyrus - adult, donor10196	10183-103D3	34.93	10.13	3.38	4.39	0.51	2.53	3.04	2.19	1.86	1.35
medial temporal gyrus, adult, donor10252	10156-103A3	28.65	22.92	6.79	12.10	0.42	9.34	7.22	4.88	3.82	6.37
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	23.12	7.71	0.00	1.93	0.00	3.85	1.93	5.78	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	14.35	0.00	14.35	57.41	0.00	315.78	258.37	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	54.92	12.20	11.13	3.59	0.72	3.95	3.23	3.59	5.03	1.44
medulla oblongata - adult, donor10196	10174-103C3	10.38	5.84	2.60	3.89	0.00	1.95	1.30	1.30	0.00	2.60
medulla oblongata, adult, donor10252	10155-103A2	14.86	7.74	13.62	16.87	1.70	2.94	4.18	4.02	1.70	6.04
medulla oblongata, adult, pool1	10038-101F2	19.75	7.02	4.90	6.45	0.98	1.14	3.27	1.47	0.82	2.94
medulla oblongata, newborn, donor10223	10361-105F1	10.42	9.37	4.17	7.29	2.43	1.39	3.47	0.35	2.43	0.35
medulloblastoma cell line:D283 Med	10838-111E1	6.64	0.00	0.00	6.64	0.00	1.77	0.00	0.66	0.66	2.44
medulloblastoma cell line:ONS-76	10759-110E3	38.03	14.92	14.92	2.81	4.16	4.77	3.06	2.32	1.47	1.59
melanoma cell line:COLO 679	10514-107E1	1.87	4.46	0.00	3.45	0.43	1.15	1.01	1.44	0.86	0.57
melanoma cell line:G-361	10465-106H6	0.00	5.97	0.00	1.36	0.00	1.09	2.99	0.54	0.27	0.27
meningioma cell line:HKBMM	10691-109F7	15.92	25.15	0.54	2.53	1.09	9.77	4.88	2.89	3.44	1.27
merkel cell carcinoma cell line:MKL-1	10843-111E6	14.98	0.00	0.00	20.27	0.00	8.81	0.00	1.76	1.76	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	26.18	8.04	1.30	7.26	0.00	6.48	2.85	1.81	1.81	2.07
mesenchymal precursor cell - adipose, donor1	11747-123G1	39.43	6.75	8.13	0.31	0.31	7.21	2.76	4.30	3.38	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	52.90	3.82	10.73	0.18	0.36	6.54	3.64	4.73	3.82	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	21.95	12.42	0.41	0.00	0.00	3.73	3.73	1.24	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	25.00	7.87	0.84	0.56	0.56	2.95	4.07	2.11	1.69	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	35.24	9.24	3.47	0.19	0.58	5.20	4.24	1.93	1.93	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	36.09	7.63	0.00	0.69	0.69	8.33	2.78	4.16	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	23.00	5.49	0.69	1.03	0.00	2.75	1.89	1.54	1.03	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	24.84	8.51	0.35	0.46	0.00	1.50	4.03	1.96	1.73	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	35.94	9.28	9.55	1.06	0.13	6.37	2.65	4.38	2.79	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	34.30	8.91	2.16	0.27	1.22	5.54	2.84	3.92	2.97	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	32.29	7.11	3.27	0.57	0.28	3.41	2.56	3.84	1.85	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	38.53	11.53	1.65	0.33	0.00	5.93	2.63	2.31	2.96	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	29.47	7.06	5.26	0.97	0.69	3.60	2.08	1.94	1.80	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	37.70	7.68	0.35	0.35	0.00	3.14	2.44	1.05	3.49	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	15.52	4.29	3.88	0.41	0.41	3.27	1.43	2.25	1.63	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	17.25	4.31	6.11	1.08	0.36	5.39	1.08	1.44	1.80	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	11.59	1.76	4.24	0.83	0.41	2.48	0.93	2.38	1.55	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.72	1.37	1.14	0.00	0.00	2.28	0.68	0.46	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	15.94	5.87	4.62	0.00	0.00	5.87	2.52	1.68	2.52	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	24.51	6.72	7.32	0.45	0.15	4.63	2.84	2.99	2.54	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	13.57	2.80	4.55	1.14	0.18	2.80	1.23	2.01	1.05	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	40.13	7.00	4.42	1.47	0.00	1.84	1.10	3.31	1.10	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	24.32	4.58	6.30	1.14	0.00	5.15	2.29	0.86	2.86	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	16.42	3.79	0.42	0.84	0.00	6.74	0.84	1.68	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	17.35	3.65	5.02	2.28	0.00	1.83	1.37	2.28	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	16.11	6.14	7.42	0.51	0.26	4.60	2.56	2.30	2.05	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	20.42	3.40	7.33	0.79	0.52	3.14	2.09	1.31	3.14	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	20.33	3.70	7.70	0.31	0.31	4.62	3.08	1.54	2.16	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	16.47	5.88	3.77	0.24	0.00	2.82	3.29	2.12	3.29	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	16.25	4.74	4.06	0.00	0.34	2.37	2.37	1.02	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	15.72	3.54	2.75	0.39	0.39	5.11	3.14	1.57	3.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	13.44	4.17	3.71	0.00	0.00	2.32	1.85	0.93	1.85	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	20.19	4.90	5.48	0.00	0.87	2.88	2.31	0.58	1.73	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	18.29	5.80	5.35	0.45	0.22	2.90	1.34	0.89	1.78	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	18.75	3.36	5.53	1.20	0.00	1.68	2.64	1.20	2.88	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	33.73	6.60	9.53	2.20	0.00	0.00	5.13	2.93	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	15.44	3.02	3.36	0.00	1.01	1.68	2.01	0.67	3.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	15.97	3.28	4.09	0.00	0.00	2.87	3.68	2.05	2.46	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	19.76	4.73	7.30	0.43	0.43	1.72	3.44	0.86	4.73	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	2.73	5.47	0.00	0.00	2.73	2.73	2.73	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	0.00	5.16	0.00	0.00	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	11.69	2.60	3.25	0.32	0.32	3.57	1.95	1.30	3.25	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	1.45	2.91	0.00	0.00	2.91	4.36	1.45	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	11.73	1.60	3.20	1.60	0.00	5.33	1.60	2.13	3.73	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	17.99	1.64	4.09	0.82	0.00	7.36	2.45	2.45	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	15.16	2.72	5.05	0.00	0.00	4.28	1.55	1.17	1.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	0.00	2.10	0.00	0.00	2.10	0.00	0.00	6.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	8.94	0.99	3.97	0.99	0.00	0.99	1.99	1.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	13.64	3.56	2.96	0.00	0.00	3.56	1.78	2.37	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	14.62	3.66	2.44	0.00	0.00	3.66	2.44	2.44	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	6.33	3.17	1.90	0.00	0.00	3.80	0.63	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	12.42	2.76	1.38	0.69	0.00	5.52	3.45	1.38	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	6.45	0.00	0.00	0.00	2.15	4.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	7.98	0.00	0.00	0.00	7.98	0.00	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	0.00	0.00	0.00	0.00	0.00	3.44	0.00	6.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	6.52	2.04	1.22	0.41	0.00	2.44	4.89	0.00	1.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	9.53	1.59	0.00	0.00	0.00	1.59	4.77	3.97	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	8.84	2.36	0.00	0.59	0.00	0.59	1.18	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	12.47	2.18	0.00	0.31	0.00	1.56	2.81	1.25	1.87	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	8.02	1.34	0.00	0.00	0.00	0.00	2.67	2.67	4.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	3.55	1.18	1.18	0.00	0.00	2.37	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	0.00	2.57	0.00	0.00	0.00	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	4.13	1.38	0.00	0.69	0.00	0.00	0.00	0.69	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	4.45	0.49	0.00	0.00	0.00	0.00	0.00	0.49	1.48	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	2.24	1.12	0.00	0.00	0.00	0.00	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	3.18	0.00	0.00	0.64	0.00	0.64	1.91	0.64	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	2.01	0.81	0.00	0.40	0.00	0.00	0.40	1.21	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	0.00	2.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1.27	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	5.46	0.00	0.00	2.43	0.00	1.21	0.61	2.43	0.00	1.82
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	0.00	0.00	0.00	0.00	9.04	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	7.41	0.00	0.00	1.65	0.00	0.82	0.82	1.65	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	5.56	0.99	0.20	0.20	0.00	1.19	1.19	0.60	0.79	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	5.19	0.32	0.32	0.00	0.00	1.95	0.32	2.60	1.30	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	10.19	1.02	0.00	1.02	0.00	4.07	3.06	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	51.84	20.89	2.32	3.09	0.00	1.55	5.42	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	13.70	0.71	2.13	2.36	0.00	2.83	0.24	2.13	0.94	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	9.73	1.39	17.14	8.34	0.00	6.95	0.70	4.63	3.24	4.40
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	0.00	0.00	0.00	0.00	0.00	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	7.19	4.32	0.31	0.62	0.00	0.21	1.34	0.51	0.41	0.00
mesothelioma cell line:Mero-25	10850-111F4	7.49	2.95	0.91	3.18	0.00	0.68	0.45	1.36	1.82	1.82
mesothelioma cell line:Mero-41	10851-111F5	6.85	5.38	3.91	1.22	0.00	3.18	1.47	2.20	1.47	0.49
mesothelioma cell line:Mero-48a	10852-111F6	9.74	3.10	3.32	1.77	0.00	2.88	1.77	1.55	1.33	0.66
mesothelioma cell line:Mero-82	10853-111F7	8.67	4.73	2.10	2.37	0.00	4.20	1.58	2.37	1.31	0.53
mesothelioma cell line:Mero-83	10854-111F8	8.17	0.85	6.81	2.55	0.00	1.53	0.34	2.38	1.70	0.68
mesothelioma cell line:Mero-84	10855-111F9	2.27	0.51	0.76	0.25	0.00	0.25	0.00	0.00	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	11.80	3.31	10.97	1.24	0.00	2.07	1.04	1.66	0.83	1.45
mesothelioma cell line:NCI-H2052	10847-111F1	14.08	2.82	0.66	1.49	0.17	2.98	2.15	1.49	0.83	0.00
mesothelioma cell line:NCI-H226	10846-111E9	16.83	0.00	2.53	1.63	0.00	1.99	0.00	0.90	0.54	2.53
mesothelioma cell line:NCI-H2452	10848-111F2	23.06	0.17	5.30	3.42	0.00	5.64	0.68	1.54	3.42	1.71
mesothelioma cell line:NCI-H28	10845-111E8	5.09	8.65	1.27	0.76	0.00	2.29	8.40	1.27	2.04	0.00
mesothelioma cell line:No36	10857-111G2	2.28	1.96	0.65	0.65	0.00	0.65	0.65	0.00	0.00	0.98
mesothelioma cell line:ONE58	10858-111G3	10.30	4.34	0.54	0.27	0.00	1.35	1.08	1.08	0.54	0.54
migratory langerhans cells, donor1	11901-125F2	94.23	54.70	0.58	0.96	3.26	3.26	15.55	5.18	1.15	0.19
migratory langerhans cells, donor2	11902-125F3	61.79	20.39	0.00	1.10	1.22	1.83	8.30	2.69	1.22	0.73
migratory langerhans cells, donor3	11903-125F4	60.66	25.13	0.54	1.79	2.15	2.51	9.33	4.13	1.62	0.90
mixed mullerian tumor cell line:HTMMT	10689-109F5	5.55	4.24	0.33	3.59	0.00	2.61	0.98	0.00	1.31	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	0.00	0.00	0.00	0.42	0.00	0.21	0.21	0.64	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	19.58	2.07	0.46	6.68	0.00	1.61	0.69	0.23	1.15	2.30
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	0.76	1.90	0.00	0.00	0.95	0.57	0.19	0.38	0.19	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	15.71	9.24	12.57	3.88	0.00	5.36	2.59	6.10	3.33	2.22
myeloma cell line:PCM6	10474-106I6	52.18	22.73	0.00	5.34	0.00	15.62	8.10	5.73	4.35	1.58
myxofibrosarcoma cell line:MFH-ino	10600-108E6	25.36	1.01	0.51	1.52	0.00	2.03	0.00	0.00	1.01	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	71.20	4.32	9.61	1.57	0.00	9.61	2.55	6.47	3.53	1.57
nasal epithelial cells, donor1, tech_rep1	12226-129F3	5.79	0.00	0.00	4.12	0.11	1.67	0.00	1.23	0.67	1.34
nasal epithelial cells, donor1, tech_rep2	12226-129F3	4.78	0.07	0.37	3.90	0.00	0.96	0.00	0.88	1.47	1.99
nasal epithelial cells, donor2	12227-129F4	20.98	0.55	3.86	4.42	1.10	0.55	1.10	0.00	1.10	2.21
neuroblastoma cell line:CHP-134	10508-107D4	8.97	0.00	0.23	19.56	0.00	2.99	0.00	1.84	1.15	4.83
neuroblastoma cell line:NB-1	10539-107G8	5.43	0.00	1.31	2.99	1.12	1.50	0.00	0.56	0.56	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	9.91	2.74	5.48	2.95	32.90	8.01	0.21	1.90	2.74	2.95
neuroblastoma cell line:NH-12	10555-107I6	21.24	10.62	1.86	13.42	0.00	7.64	5.78	4.85	3.73	6.34
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	40.80	22.77	12.57	12.81	0.00	9.73	3.80	5.46	2.85	6.17
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	24.71	3.17	2.69	6.97	12.35	7.29	2.22	9.34	2.69	2.69
neuroectodermal tumor cell line:TASK1	10774-110F9	14.29	0.20	5.03	3.42	1.01	6.64	0.20	3.82	2.82	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	10.81	0.64	1.27	1.27	0.64	0.64	1.91	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	104.60	15.70	25.02	1.06	1.60	18.10	3.46	7.98	5.59	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	74.37	133.87	0.00	0.00	0.00	29.75	0.00	14.87
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	13.28	0.00	0.00	0.00	0.00	0.00	13.28
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	69.00	23.51	5.75	8.63	2.20	11.33	7.78	2.88	0.34	3.38
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	7.20	36.82	0.80	4.80	0.00	0.80	2.40	1.60	0.00	4.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	24.69	4.81	2.56	2.56	0.00	4.17	1.92	4.49	1.28	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	1.84	2.89	0.00	0.26	0.26	2.10	0.79	0.26	0.53	0.00
nucleus accumbens, adult, pool1	10037-101F1	55.87	8.06	11.62	6.00	0.75	3.19	2.53	4.31	2.81	1.69
occipital cortex - adult, donor10196	10172-103C1	41.21	10.30	4.12	8.24	2.06	6.18	2.06	2.06	6.18	2.06
occipital cortex, adult, donor10252	10163-103B1	29.79	17.98	9.66	20.40	0.81	11.27	6.44	8.86	5.64	8.32
occipital cortex, newborn, donor10223	10355-105E4	64.42	9.46	8.01	3.64	0.73	3.64	5.10	0.73	4.37	0.73
occipital lobe, adult, donor1	10076-102A4	30.44	7.08	3.15	4.72	0.00	7.08	2.10	6.04	4.20	1.31
occipital lobe, fetal, donor1	10073-102A1	163.92	6.01	24.46	5.58	1.72	11.16	2.15	11.59	4.29	0.86
occipital pole, adult, pool1	10036-101E9	19.47	6.62	4.49	2.13	0.63	1.42	1.42	1.02	0.71	1.10
olfactory region, adult	10195-103E6	35.15	5.54	3.63	2.29	0.57	4.59	2.29	7.45	3.25	2.48
optic nerve, donor1	10277-104E7	48.03	4.00	4.00	12.01	0.00	6.00	0.00	0.00	2.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	8.77	1.03	1.14	7.97	0.00	3.08	1.37	0.68	0.46	2.73
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	5.50	10.03	4.26	4.26	0.00	2.20	1.51	1.92	2.06	1.51
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	8.47	1.86	2.71	0.51	0.00	0.85	1.02	0.51	0.85	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	5.20	0.46	1.39	3.35	0.00	1.96	0.00	1.39	0.81	1.27
osteoclastoma cell line:Hs 706.T	10704-109H2	0.00	25.87	0.00	5.29	0.00	6.17	9.41	2.65	3.53	1.76
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	44.85	33.64	8.41	12.15	0.00	2.80	2.80	3.74	2.80	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	7.21	6.57	4.45	0.85	1.70	1.70	1.91	1.27	1.06	1.06
ovary, adult, pool1	10020-101D2	42.28	55.47	3.32	8.39	1.92	2.62	14.85	2.71	2.10	3.84
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	24.93	10.27	15.03	1.47	0.00	4.58	2.57	5.68	2.20	0.73
pancreas, adult, donor1	10049-101G4	18.81	5.64	0.94	22.58	0.00	2.82	5.64	9.41	4.70	9.41
pancreatic carcinoma cell line:NOR-P1	10698-109G5	0.00	0.00	0.00	11.74	0.00	2.80	0.00	1.68	0.56	1.40
papillary adenocarcinoma cell line:8505C	10437-106E5	10.56	2.38	0.17	4.60	0.17	3.58	1.87	1.02	1.02	1.19
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	24.34	1.66	6.46	14.74	0.50	3.81	0.33	4.47	1.49	4.64
paracentral gyrus, adult, pool1	10035-101E8	25.99	10.53	3.75	3.20	0.46	1.92	1.01	2.38	1.46	1.92
parietal cortex, adult, donor10258	10373-105G4	33.03	5.87	5.87	0.73	2.20	3.67	0.00	0.00	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	24.45	4.70	2.82	5.64	0.00	6.58	1.88	4.70	2.82	0.00
parietal lobe, adult, donor10252	10157-103A4	29.07	23.37	4.85	9.69	0.57	7.70	6.84	9.12	3.71	6.84
parietal lobe, adult, pool1	10034-101E7	26.61	9.96	3.79	4.76	0.35	2.38	2.20	2.03	1.50	2.47
parietal lobe, fetal, donor1	10072-101I9	143.54	4.85	43.64	17.46	4.85	40.73	0.00	18.43	3.88	0.97
parietal lobe, newborn, donor10223	10356-105E5	43.37	10.84	8.22	4.49	2.62	8.97	5.23	1.50	5.23	0.75
parotid gland, adult	10199-103F1	38.85	16.03	0.62	11.72	4.93	12.33	3.08	5.55	5.55	6.78
penis, adult	10200-103F2	62.84	19.87	16.65	8.06	2.15	15.58	9.13	3.76	2.15	3.76
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	29.56	2.05	0.19	4.09	0.00	3.16	2.05	0.37	0.74	1.86
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	13.11	8.60	4.37	4.81	0.00	3.79	1.46	4.81	1.46	2.04
pineal gland - adult, donor10196	10179-103C8	7.74	1.94	1.94	4.52	1.29	2.58	1.29	1.29	0.00	1.94
pineal gland, adult, donor10252	10160-103A7	5.92	4.15	2.96	14.81	0.59	2.96	3.55	1.78	0.00	4.74
pineal gland, adult, donor10258	10377-105G8	3.76	1.88	0.63	2.51	0.00	1.25	1.25	0.00	0.00	1.25
pituitary gland - adult, donor10196	10180-103C9	12.14	55.65	7.08	13.15	2.02	2.02	12.14	2.02	3.04	4.05
pituitary gland, adult, donor10252	10162-103A9	31.27	123.00	4.17	33.88	1.56	5.73	36.48	3.65	0.52	17.72
pituitary gland, adult, donor10258	10378-105G9	10.21	33.20	5.11	7.66	1.70	2.55	9.36	4.26	0.85	4.26
placenta, adult, pool1	10021-101D3	10.86	8.17	1.72	9.78	0.32	1.51	1.29	1.29	1.29	2.69
plasma cell leukemia cell line:ARH-77	10840-111E3	1.99	1.99	0.00	0.26	0.00	0.13	0.26	0.13	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	22.72	39.53	3.58	3.42	0.47	7.63	9.65	6.38	2.80	1.25
pons, adult, pool1	10033-101E6	17.04	5.16	2.75	4.30	0.52	1.55	1.38	1.29	1.64	1.89
postcentral gyrus, adult, pool1	10032-101E5	20.14	6.54	2.96	3.05	0.35	3.14	1.31	2.27	2.27	1.22
promyelocytes/myelocytes PMC, donor1	12132-128D8	6.27	0.00	112.94	81.56	0.00	0.00	0.00	0.00	0.00	14.64
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	22.03	0.00	5.51	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	0.58	0.15	0.15	1.46	0.00	0.29	0.15	0.29	0.00	0.58
prostate cancer cell line:PC-3	10439-106E7	52.82	3.27	5.99	5.26	1.45	7.62	0.91	5.45	3.27	2.90
prostate, adult, pool1	10022-101D4	39.09	32.20	10.25	12.15	2.63	3.36	8.98	3.36	2.45	5.44
putamen, adult, donor10196	10176-103C5	60.90	5.19	15.34	4.01	0.24	12.04	0.47	10.15	7.55	1.65
putamen, adult, donor10252	10152-102I8	43.14	7.84	21.57	11.76	1.96	11.76	0.00	0.00	13.73	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	42.62	1.09	5.46	1.09	8.74	3.28	1.09	1.09	1.09	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	71.03	2.17	14.26	3.38	0.48	4.59	0.97	5.07	3.62	0.97
putamen, newborn, donor10223	10365-105F5	26.24	19.49	17.99	2.25	4.50	10.50	9.75	3.00	5.25	0.00
rectal cancer cell line:TT1TKB	10469-106I1	0.87	4.65	0.00	1.16	0.00	0.29	0.87	0.58	0.00	0.00
rectum, fetal, donor1	10067-101I4	100.15	44.51	19.47	23.65	20.86	13.91	20.86	22.26	0.00	5.56
renal cell carcinoma cell line:OS-RC-2	10411-106B6	3.18	1.70	2.12	0.42	0.00	1.48	1.91	0.21	0.21	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	1.66	1.24	2.07	2.07	0.00	2.90	2.49	1.66	0.00	0.41
retina, adult, pool1	10030-101E3	29.22	13.52	10.34	11.43	1.89	2.09	4.87	3.28	1.69	5.86
retinoblastoma cell line:Y79	10475-106I7	5.98	0.00	0.52	22.60	0.00	3.90	0.00	2.60	1.30	4.94
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.00	0.00	0.00	5.78	0.00	0.98	0.00	0.61	0.49	1.97
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	10.69	7.87	0.28	1.41	0.00	3.66	6.47	1.69	1.12	1.69
sacrococcigeal teratoma cell line:HTST	10695-109G2	59.87	20.46	11.37	5.30	0.76	3.03	5.30	1.52	1.52	0.76
salivary acinar cells, donor1	11771-123I7	22.17	0.97	6.31	3.24	0.81	2.27	0.49	2.10	0.97	1.78
salivary acinar cells, donor2	11772-123I8	17.62	1.65	5.23	6.20	0.14	1.65	0.96	0.69	0.14	2.48
salivary acinar cells, donor3	11773-123I9	32.44	2.65	7.94	15.23	0.00	1.32	1.32	1.99	1.32	5.96
salivary gland, adult, pool1	10093-102C3	33.17	41.75	9.15	17.16	8.01	11.44	7.44	10.30	1.14	8.58
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	24.45	17.62	0.08	0.51	0.08	4.30	8.18	1.35	1.35	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	21.63	15.75	0.24	0.59	0.24	4.23	6.47	2.94	0.94	0.12
seminal vesicle, adult	10201-103F3	23.28	6.35	2.12	12.70	0.53	6.88	5.82	1.06	2.65	8.47
serous adenocarcinoma cell line:JHOS-2	10639-108I9	8.02	3.40	1.94	3.89	0.00	4.13	1.21	1.46	0.49	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	7.80	1.51	3.02	0.50	0.00	0.75	0.25	1.51	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	10.04	2.01	12.04	3.01	0.00	6.02	1.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	3.63	0.00	2.96	6.58	0.40	2.55	0.00	1.07	1.48	1.88
signet ring carcinoma cell line:Kato III	10436-106E4	21.66	0.88	0.11	5.64	0.11	5.53	0.44	1.44	1.66	2.21
signet ring carcinoma cell line:NUGC-4	10483-107A6	27.87	30.45	1.16	5.94	0.65	7.74	9.68	4.90	4.52	1.55
skeletal muscle - soleus muscle, donor1	10282-104F3	22.70	4.97	1.42	25.54	0.00	4.26	2.84	1.42	0.71	4.26
skeletal muscle, adult, pool1	10023-101D5	23.03	10.31	2.40	7.92	0.72	3.00	3.84	2.04	1.92	2.88
skeletal muscle, fetal, donor1	10066-101I3	29.15	9.05	3.02	6.03	0.00	2.01	2.01	2.01	0.00	1.01
skin, adult, donor1	10074-102A2	27.14	0.00	0.00	0.00	0.00	13.57	6.79	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	32.19	12.62	8.21	15.78	3.16	3.16	5.05	3.16	3.16	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	87.38	17.01	0.67	7.67	4.34	14.01	5.34	10.01	6.67	3.34
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	11.35	5.67	2.21	21.43	8.20	5.36	3.78	4.73	2.52	18.60
small cell lung carcinoma cell line:DMS 144	10841-111E4	0.58	0.00	0.00	0.96	0.00	0.77	0.00	0.19	0.19	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	13.85	2.14	13.35	12.20	70.22	7.75	0.16	7.58	4.94	9.07
small cell lung carcinoma cell line:NCI-H82	10842-111E5	0.97	0.00	0.00	3.06	0.00	0.32	0.00	0.32	0.32	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	30.73	60.80	3.27	14.60	15.04	9.81	5.88	3.92	3.92	8.28
small intestine, adult, pool1	10024-101D6	14.93	34.16	2.51	14.09	2.03	5.73	12.78	5.85	5.61	10.39
small intestine, fetal, donor1	10064-101I1	26.78	11.55	2.70	5.65	14.00	6.63	5.16	13.27	5.16	2.70
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	43.60	24.11	2.56	5.13	0.00	18.46	2.56	6.15	6.67	4.62
smooth muscle, adult, pool1	10048-101G3	68.75	27.40	20.42	7.50	4.91	7.50	9.30	13.44	5.17	3.36
somatostatinoma cell line:QGP-1	10781-110G7	28.95	38.06	0.27	14.74	0.00	2.95	5.36	2.14	0.80	5.36
spinal cord - adult, donor10196	10181-103D1	17.89	7.80	2.06	7.80	0.23	1.38	3.44	0.46	2.29	2.52
spinal cord, adult, donor10252	10159-103A6	15.38	7.10	5.52	13.41	0.79	3.55	2.37	1.18	1.97	7.49
spinal cord, adult, donor10258	10369-105F9	7.61	6.23	0.69	2.08	0.69	0.69	2.77	2.08	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	57.32	10.98	17.69	12.81	4.27	3.66	2.44	11.59	4.88	1.83
spinal cord, newborn, donor10223	10359-105E8	7.35	18.37	1.38	17.91	0.92	1.84	8.27	0.46	2.30	8.73
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	72.59	5.53	22.10	1.49	1.34	3.88	1.05	4.78	2.24	0.90
spleen, adult, pool1	10025-101D7	15.75	41.63	1.21	6.06	16.74	2.97	6.50	2.86	1.98	1.87
spleen, fetal, pool1	10044-101F8	19.31	41.79	2.62	11.36	28.60	1.43	9.22	0.56	0.72	3.26
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	3.93	1.14	0.00	3.93	0.10	1.04	0.62	0.93	0.72	1.14
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	4.75	0.57	0.57	6.84	0.00	3.42	0.38	2.09	1.52	2.28
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	3.84	1.75	0.35	1.75	0.00	1.05	0.00	1.05	1.05	2.10
squamous cell carcinoma cell line:T3M-5	10616-108G4	19.16	0.00	0.78	4.69	0.00	2.35	0.00	0.39	1.17	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	3.26	1.01	0.11	3.15	0.00	1.91	0.11	0.90	0.56	1.01
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	0.85	0.42	0.00	2.12	0.00	1.27	0.85	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	15.65	7.19	1.27	0.85	0.00	1.27	5.50	0.85	0.85	0.42
stomach, fetal, donor1	10062-101H8	110.00	28.84	14.95	18.16	1.07	16.02	8.54	9.61	3.20	7.48
submaxillary gland, adult	10202-103F4	47.85	17.66	13.10	19.94	20.51	7.41	5.70	2.85	2.85	7.41
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	108.55	0.00	271.37	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	15.79	7.69	3.12	16.82	1.04	6.23	1.45	1.25	3.32	5.61
substantia nigra, adult, donor10258	10371-105G2	6.72	1.03	1.03	1.03	0.00	1.55	1.55	0.00	0.52	1.55
substantia nigra, newborn, donor10223	10358-105E7	12.01	14.84	4.95	10.60	1.41	2.12	2.12	0.71	0.71	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	24.53	5.96	19.03	3.44	0.46	9.86	2.52	4.13	2.75	1.83
temporal lobe, adult, pool1	10031-101E4	21.62	5.17	2.03	2.20	0.25	0.93	1.44	2.03	1.19	1.02
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	163.11	4.27	22.79	7.83	2.14	16.38	2.85	14.96	4.27	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	101.53	7.91	18.02	4.40	1.76	12.31	1.32	2.64	3.96	0.88
tenocyte, donor1	11763-123H8	44.68	5.24	5.59	0.35	0.00	5.24	3.14	7.33	4.19	1.40
tenocyte, donor2	11765-123I1	30.14	10.68	9.54	1.53	0.76	8.39	4.20	6.49	5.72	0.38
tenocyte, donor3	11768-123I4	19.65	4.08	1.48	0.37	0.00	7.04	1.48	4.45	1.85	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	3.57	2.55	0.51	3.74	15.64	2.55	1.70	2.89	1.19	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	33.60	0.62	8.79	4.62	3.39	3.39	0.46	5.86	3.85	1.08
teratocarcinoma cell line:PA-1	10807-111A6	1.08	1.70	0.15	3.25	6.66	0.62	0.31	1.39	0.15	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	6.35	0.51	0.00	1.90	8.38	0.25	0.25	1.27	0.51	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	12.10	0.00	0.76	4.92	24.96	4.54	0.00	1.51	1.89	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	2.40	0.44	0.22	3.05	2.29	0.55	0.33	0.55	0.11	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	8.47	0.98	3.26	5.54	8.14	3.58	1.63	1.63	1.30	0.98
testis, adult, pool1	10026-101D8	22.98	16.32	2.58	4.08	0.97	3.01	9.99	3.54	1.72	1.93
testis, adult, pool2	10096-102C6	19.40	4.96	1.35	5.41	0.90	5.41	5.41	1.35	1.35	0.90
thalamus - adult, donor10196	10168-103B6	19.87	2.21	3.31	3.31	0.00	4.42	0.00	2.21	1.10	1.10
thalamus, adult, donor10252	10154-103A1	25.47	7.35	7.50	18.91	0.63	5.31	4.06	5.16	3.13	6.72
thalamus, adult, donor10258, tech_rep1	10370-105G1	33.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	18.28	2.31	1.15	3.46	0.33	2.14	1.32	1.98	1.32	0.82
thalamus, newborn, donor10223	10366-105F6	4.03	6.90	1.15	2.88	1.73	4.03	2.30	1.15	2.30	0.00
throat, adult	10209-103G2	30.21	18.23	6.24	8.74	4.24	4.74	6.74	2.25	1.75	3.75
throat, fetal, donor1	10061-101H7	36.26	32.60	6.70	17.37	7.31	4.88	9.14	12.49	4.88	5.48
thymic carcinoma cell line:Ty-82	10803-111A2	0.20	0.00	0.00	0.20	0.00	0.00	0.00	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	15.31	113.33	0.80	13.22	37.38	2.68	14.71	1.79	1.89	4.77
thymus, fetal, pool1	10043-101F7	33.35	158.66	4.26	15.79	53.72	3.32	23.79	3.74	3.12	5.61
thyroid carcinoma cell line:KHM-5M	10776-110G2	15.56	1.86	2.26	0.80	0.00	2.39	1.46	1.20	1.06	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	8.24	2.10	1.40	2.37	0.00	1.26	0.70	1.82	0.84	1.12
thyroid, adult, pool1	10028-101E1	8.96	62.52	2.89	20.81	1.77	5.23	8.96	2.80	3.64	5.60
thyroid, fetal, donor1	10060-101H6	43.50	38.23	5.80	30.58	7.38	5.80	6.59	9.23	4.48	11.07
tongue epidermis (fungiform papillae), donor1	10288-104F9	73.91	18.48	6.16	43.11	9.24	9.24	30.80	0.00	15.40	9.24
tongue, adult	10203-103F5	30.00	11.40	3.49	5.35	1.16	4.42	5.58	2.09	1.63	1.86
tongue, fetal, donor1	10059-101H5	21.28	8.28	0.79	5.12	1.58	1.97	4.34	13.40	4.34	2.36
tonsil, adult, pool1	10047-101G2	50.19	63.41	4.81	5.01	26.65	3.41	9.42	3.51	2.50	3.91
trachea, adult, pool1	10029-101E2	41.06	35.09	5.81	7.93	2.54	3.84	7.93	4.34	2.21	3.84
trachea, fetal, donor1	10058-101H4	61.94	26.16	9.62	17.70	6.92	10.39	6.54	20.00	4.23	4.23
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	52.43	8.50	4.61	1.77	0.71	9.92	4.61	8.86	1.42	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	15.81	15.50	9.42	3.24	0.61	3.85	2.53	2.63	1.93	1.22
transitional-cell carcinoma cell line:JMSU1	10492-107B6	2.19	0.94	0.47	6.74	0.00	1.57	0.47	1.88	0.47	1.41
tridermal teratoma cell line:HGRT	10694-109G1	53.27	9.51	7.61	1.90	0.00	7.61	7.61	3.81	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	3.30	6.09	0.17	3.22	0.76	0.76	2.29	1.10	0.59	0.76
umbilical cord, fetal, donor1	10057-101H3	35.47	8.35	2.09	4.17	0.00	2.09	4.17	10.43	0.00	0.00
uterus, adult, pool1	10100-102D1	40.78	39.07	11.60	14.84	1.02	4.78	14.67	2.39	1.19	5.46
uterus, fetal, donor1	10055-101H1	27.13	20.99	1.02	7.17	1.02	1.54	9.73	12.29	3.07	2.56
vagina, adult	10204-103F6	53.63	40.71	5.17	23.91	0.00	1.94	7.75	0.65	1.29	4.52
vein, adult	10191-103E2	46.47	35.73	6.36	4.38	20.60	8.33	5.26	4.38	3.29	1.32
xeroderma pigentosum b cell line:XPL 17	10563-108A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00